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ABSTRACT
Muscle weakness is the most common and persistent problem after a critical illness. Early
mobilization of the critically ill patient, beginning with passive exercise and progressing to
ambulation, may mitigate muscle effects of the critical illness. However, mobilization may
produce adverse effects, especially early in the illness when risk for physiologic deterioration is
common. If safe, introducing a mobility intervention early in the illness may facilitate ventilator
weaning, shorten intensive care unit and hospitals stays, and improve functional status and
quality of life for mechanically ventilated critically ill patients.
The aim of this study was assess the cardiopulmonary and inflammatory responses to an
early standardized passive exercise protocol (PEP) in mechanically ventilated critically ill
patients. Using a quasi-experimental within-subjects repeated measures design, mechanically
ventilated critically ill adults who were physiologically stable received a single standardized PEP
within 72 hours of intubation. The PEP consisted of 20 minutes of bilateral passive leg
movement delivered by continuous passive motion machines at a rate of 20 repetitions per
minute, from 5-75 degrees, to simulate very slow walking. Physiologic parameters evaluated
included heart rate (HR), mean blood pressure (MBP), oxygen saturation, and cytokine levels
(IL-6 and IL-10), obtained before, during, and after the intervention. The Behavioral Pain Scale
(BPS), administered before, during and after the intervention was used as a measure of
participant comfort.
The study sample was comprised of 18 (60%) males and 12 (40%) females, with a mean
age of 56.5 years (SD 16.9 years), who were primarily Caucasian (N=18, 64%). Mean APACHE
II scores for the sample were 23.8 (SD 6.2) with a mean predicted death rate of 48.8 (SD 19.8),
indicating moderate mortality risk related to illness severity. Number of comorbidities ranged
iii

from 1-10 (X=4). All participants completed the intervention with no adverse events. Using
repeated measures analysis of variance (rmANOVA), no significant differences were found in
HR, MBP, or oxygen saturation at any of the four time points in comparison to baseline. BPS
scores were significantly reduced (F(2.43, 70.42)=4.08, p=.02) at 5 and 10 minutes after the
PEP was started, and were sustained at 20 minutes and for one hour after the PEP was
completed. IL-6 was significantly reduced (F(1.60, 43.1)=4.351, p=.03) at the end of the
intervention but not at the end of the final rest period. IL-10 values were not significantly
different at any of the three time points, but IL-6 to IL-10 ratios did decrease significantly
(F(1.61, 43.38)=3.42, p=.05) at the end of the PEP and again after a 60 minute rest period.
Passive leg exercise was well tolerated by study participants. HR, MBP, and oxygen saturation
were maintained within order set-specified ranges during and for one hour after activity, and
patient comfort improved during and after the intervention. A downward trend in HR was noted
in participants, which is contrary to usual HR response during exercise, and may represent
clinical improvement in this population related to reduction in pain. Reduction of mean IL-6
values at the end of the PEP, but not after the rest period, suggests that the PEP was responsible
for the initial IL-6 improvement. Improvement of IL-6 to IL-10 ratios from the end of the PEP
to the end of the final rest period suggests that IL-10, although non-significant, may have had
some effect, indicating that IL-10 increases may occur later than the time period of study.
Passive exercise can be used as an approach to facilitating mobilization in mechanically
ventilated critically ill adults until they are ready to participate in more active exercise. It could
be that more frequent and aggressive exercise, such as passive cycling at faster rates, four times
daily, will be tolerated in this population. While the understanding of clinical significance of
cytokine profiles in critically ill patients is still evolving, cytokine levels may be useful in
iv

explaining benefits of mobilization in this population. Further study is required to replicate the
impact of passive exercise on pain, and it may represent a novel approach to pain management in
critically ill patients.
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CHAPTER ONE: INTRODUCTION
Muscle weakness is the most common complication of critical illness, as well as the most
persistent problem after a critical illness.1 Fatigue, poor functional status and decreased healthrelated quality of life one year after a critical illness are all attributed to persistent muscle
weakness.4 The muscle weakness associated with critical illness is due to immobility as well as
inflammation.3 Inflammation diminishes both muscle mass and strength. Inflamed muscle is
problematic in that it can prolong need for mechanical ventilation, extend hospital stay, and
complicate recovery, as well as negatively impact quality of life for the individual with critical
illness.4 Mobilization is one approach to mitigating inflammation and muscle weakness after a
critical illness.5 It covers a wide range of progressive activities, from passive and active range of
motion (ROM), to dangling, standing or lift transfer to a chair, and ambulation.1,6,7 Mobilization
is thought to preserve muscle strength and mass by improving blood flow, stimulating antiinflammatory cytokine production and enhancing insulin activity and glucose uptake in muscle.3
Mobilization has been shown to improve outcomes for critically ill adults.1,8 Improved
outcomes include earlier ambulation, shorter lengths of intensive care unit (ICU) and hospital
stays, and improved functional status as well as quality of life.1,2,8 Whether a decrease in
inflammation could be directly attributed to activity and improved outcomes is not yet known,
but preliminary evidence suggests that 20 minutes of sustained activity daily can improve
cytokine profiles in critically ill patients.9
Mobilization protocols, beginning with passive activity and advancing to ambulation,
have been studied as a step-wise approach to activity progression but many study participants
have been unable to move beyond passive activity.1, 8 Primary reasons for failure to progress
were decreased responsiveness and physiologic instability.1, 6, 8 Physiologic instability in
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mechanically ventilated critically ill patients may persist for days to weeks, delaying use of
active mobility interventions. Passive exercise, a routine nursing procedure, may be the most
appropriate activity for these patients in the early phase of illness.10 However, limited empirical
evidence exists to support the safety or efficacy of passive activity, particularly during periods of
physiologic instability, and criteria to document readiness to institute active mobilization have
not yet been developed. Tolerance of passive activity may be one signal that progression is
appropriate.
Patient tolerance appears to be the limiting factor in application of mobilization
activities.10,11 Commonly used bedside physiologic measures, such as heart rate and blood
pressure, have been suggested as approaches to identifying patient tolerance,6, 11 and preliminary
research has demonstrated physiologic stability in mechanically ventilated critically ill patients
who were mobilized 5 days or longer after intubation.12 However, waiting to start mobilization
for 5 days or longer after intubation may miss an important window of opportunity to improve
patient outcomes. Loss of muscle mass and strength is evident soon after critical illness onset;
2% of mass may be lost within the first 24 hours of critical illness.3,10 With muscle changes
appearing soon after onset of critical illness,13 it is logical to consider implementation of
mobilization soon after illness onset, as delay may add to disability.14
Concern has been expressed about early mobilization contributing to increased muscle
inflammation, which may actually compound rather than prevent muscle weakness.15
Inflammatory markers did not change significantly with passive activity (< 15 min), suggesting
that passive activity does not increase inflammation.16 However, further study would add to
safety support for this measure.
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To date, limited study has been done to evaluate safety of passive activity in early critical
illness. Chapter 2 provides a review of the state of the science related to passive activity in
critical illness. Passive activity, if demonstrated to be safe, may provide early benefit to those
critically ill patients who are not yet able to tolerate progressive activity. Introducing a
mobilization intervention early in the illness may facilitate weaning, shorten intensive care unit
and hospitals stays, and improve quality of life for mechanically ventilated critically ill patients.

Study Purpose and Aims
The aim of this study was to assess the physiologic responses to a standardized passive
exercise intervention instituted within 72 hours of intubation in mechanically ventilated critically
ill patients. The specific research questions asked were:
1. What is the cardiopulmonary response to an early passive exercise protocol (PEP) in
mechanically ventilated critically ill patients?
2. What is the intracranial pressure (ICP) response to an early passive exercise
protocol (PEP) in mechanically ventilated critically ill patients?
3. What is the behavioral pain response to an early passive exercise protocol (PEP) in
mechanically ventilated critically ill patients?
4. What is the inflammatory response to an early passive exercise protocol (PEP) in
mechanically ventilated critically ill patients?

Theoretical Framework
The muscle weakness associated with critical illness is thought to be due to inflammation
rather than immobility. A theoretical framework focused on inflammation is relevant to the study
of critical illness myopathy, as it provides a more rational explanation for the muscle weakness
3

that occurs with critical illness than immobility alone. In muscle that has been immobilized,
myosin filaments are typically retained while actin fibers are lost, leading to significant loss in
mass and but not strength.5 In contrast, inflamed muscle has been observed to lose both myosin
and actin,5 supporting the concept that inflammation plays a significant role in muscle weakness.
Critical illness typically invokes a systemic inflammatory response.17 Muscle weakness in
critical illness represents a type of organ failure secondary to this systemic inflammatory
response.5 The systemic inflammatory response is thought to affect the muscle as follows.
Catecholamines released during the inflammatory response bind to muscle cell receptor
sites to stimulate muscle proteolysis. The protective purpose of proteolysis is to provide readily
available amino acids for gluconeogenesis. High catecholamine levels not only contribute to
muscle protein loss, but also can also suppress protein synthesis through cytokine mechanisms.18
Catecholamines upregulate the expression of the pro-inflammatory cytokines, IL-1 and tumor
necrosis factor-alpha (TNF-a), which can have adverse effects on muscle. TNF-a affects muscle
regeneration by inactivating a muscle proliferation transcription factor,19 which ultimately
decreases protein synthesis, resulting in decreased muscle mass. Concomitantly, IL-1a generates
free radicals, which damage myosin filaments, resulting in decreased strength.18,19 TNF-a also
reacts with muscle receptors that block aerobic protein metabolism, thereby creating oxidative
stress in the muscle, ultimately decreasing contractility.19
IL-1 activates IL-6, which has both pro- and anti-inflammatory effects. IL-6 stimulates
neutrophil maturation and natural killer (NK) cell differentiation, but it also promotes release of
anti-inflammatory cytokines and downregulates IL-1 and TNF-a over time.19 Muscle cells have
receptors for IL-6; those IL-6 receptors are thought to contribute to muscle proteolysis by
recruiting infiltrative inflammatory products such as prostaglandins.19 Muscle cells also express
4

IL-6, and this expression is thought to be linked to the glucose metabolism that is necessary for
energy production and muscle repair.19 In a homeostatic state, IL-6 activates IL-10, which
mediates effects of IL-1, IL-6 and TNF-a, thus protecting muscle. Sustained production of proinflammatory cytokines can suppress anti-inflammatory cytokines.19 Imbalance of pro- and antiinflammatory cytokines is thought to contribute to muscle breakdown and impairment of repair
mechanisms that characterizes the muscle weakness seen in critical illness.20
Systemic inflammation also produces cytokine-mediated microcirculatory changes. IL-1
increases endothelial adhesion of lymphocytes through activation of cell adhesion molecules, a
process designed to prevent microbial invasion. As cells adhere, thrombosis of microcirculation
and consequent muscle ischemia and micro-infarction can occur.21 Tissue hypoxia upregulates
IL-1 and TNF-a expression, compounding the process. Capillary permeability is also increased
in the inflammatory response, due to expression of IL-1b, which stimulates release of
prostaglandins. The resulting vascular permeability may allow greater exposure of muscle cells
to cortisol. Cortisol is implicated in what has been termed an “acquired channelopathy,” in which
cortisol binding on muscle receptor sites dysregulates the sodium channels, resulting in
decreased excitability of the muscle.18
Hyperglycemia is an additional factor in muscle damage. The relative insulin resistance
produced in response to increased cortisol levels can exacerbate muscle catabolism.5, 18, 19 Insulin
has been found to play an important role in preventing muscle proteolysis as well as promoting
muscle repair. Maintenance of normoglycemia may protect muscle.22
Prevention of muscle weakness in critical illness focuses on decreasing inflammation,
promoting blood flow, and restoring normoglycemia.22 Mobilization activities may produce all
three benefits, and even passive activities may provide some muscle protection (Figure 1).
5

Figure 1. Interactions of inflammatory responses on muscle metabolism. Note that IL-1, IL-6,
and TNF-α act as mediators for the inflammatory cascade. Not depicted here is the action of IL10. As an anti-inflammatory cytokine, IL-10 is activated by IL-6 to mediate (downregulate)
expression of IL-1 and TNF-α, in effect inactivating the inflammatory response.

Pedersen and Hoffman-Goetz suggest that activity and exercise stimulate release of
inhibitory factors that decrease or turn off the inflammatory response.23 The inhibitory factors are
IL-1ra, which blocks IL-1 activity, and IL-10 which provides anti-inflammatory balance to the
pro-inflammatory IL-6. Thus, activity mediates the magnitude and duration of the inflammatory
6

response.23 Activity has been noted to increase pro-inflammatory cytokines, specifically IL6.23,24 However, the increase in IL-6 appears to be related to intense, prolonged exercise which
typically would not be expected in the critical care setting. Similarly, decreased activity
tolerance, which is anticipated in the critical care setting, has also been associated with an
increase in IL-6.23 Further evidence suggests that the IL-6 may be muscle-derived rather than
circulating IL-6, which may actually contribute to muscle repair and protection.20,24 Muscle
activity has also been purported to reduce small vessel compression and improve blood flow
which may reduce inflammatory factors present in the muscle.24 Low resistance exercise,
including passive or active range of motion, has been found to increase muscle blood flow and
oxygen supply. Continuous passive exercise in one leg three times a day for seven days
improved muscle blood flow and prevented myopathy in the treated leg in 5 critically ill
patients.25 Exercise also decreases insulin resistance,24, 26 which may modulate the effects of
hyperglycemia on muscle.
The inflammation framework provides multiple defined targets for intervention. The
physiologic responses in the framework serve as measurement points that may be used to
determine safety or efficacy of targeted interventions. The framework also crosses disciplines,
so its utility is not limited to nursing alone. The major limitation in using this framework is that
inflammation is a systemic response, not limited to muscle. It is feasible that other systemic
effects may intervene, limiting therapeutic effects of any targeted interventions. In addition, the
immune system focus limits additional factors, such as psychological stress, from contributing to
outcomes.

7

Physiologic Responses to Passive Activity
Identifying safety and feasibility of a passive exercise intervention is a crucial first step in
adopting prescribed mobilization into the multidisciplinary plan of care for a critically ill patient.
This research study sought to provide safety and feasibility support in advance of a larger study
that would evaluate efficacy of a progressive exercise intervention in critically ill patients.
Following Institutional Review Board approval and after obtaining proxy consent, 30
mechanically ventilated critically ill adults from three intensive care units (neuroscience,
multisystem, and trauma) in one tertiary care center were enrolled in the study. Following a rest
period, participants underwent a 20 minute passive exercise protocol followed by an additional
rest period. Physiologic variables, including heart rate, blood pressure, oxygen saturation,
intracranial pressure, cytokine levels, and behavioral pain response, were monitored at specified
time points throughout the study. Details of the study and its findings are found in Chapter 3.
Measurement of physiologic responses to mobilization presents several unique challenges
in the critical care setting. The ability to replicate study findings and apply results to practice
requires the selection of optimum variables to measure, appropriate timing of variable
measurement, and adoption of approaches to assuring precision and accuracy in measurement.
Issues related to measurement of physiologic variables appropriate for this study and setting are
addressed in Chapter 4.
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CHAPTER 2: LITERATURE REVIEW
Abstract
Muscle weakness is the most common and persistent problem after a critical illness. Early
mobilization of the critically ill patient, beginning with passive exercise and progressing to
ambulation, may mitigate muscle effects of critical illness. Although mobilization is quickly
being incorporated into care for critically ill patients, standards for mobilization interventions are
lacking. To identify evidence supporting timing and type of mobilization interventions for
critically ill patients, a comprehensive literature search of electronic databases was conducted
from 1990 to present, including CINAHL, MEDLINE the Cochrane Database of Systematic
Reviews, and PubMed. Search terms used were mobilization, exercise, activity, and critical
illness. Fifteen articles were identified for review. The analysis focused on what constitutes
mobilization, which patients should receive it and when, and who should provide mobilization
interventions.
The analysis revealed that a “toolbox” of mobilization activities is available to the
bedside practitioner but specific guidelines for how and when to implement those activities are
limited. Although early mobilization is advocated in literature, clear definition of “early” was
lacking. Strict study inclusion criteria limited patient involvement in mobilization activities.
Several different practitioners delivered mobilization interventions but most protocols were
driven by physical therapists rather than nurses, although a team approach was advocated.
Knowledge that supports decisions about how and when to mobilize critically ill patients is
evolving. Comparing study outcomes is challenging with treatment routines varying so
widely. Clinical trials that incorporate progressive mobilization across broad population of
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critically ill patients are needed, along with studies that demonstrate that mobilization protocols
can be implemented into practice at the bedside.

Introduction
Muscle weakness is the most common and persistent problem after a critical illness.1
Fatigue, poor functional status and decreased health-related quality of life one year after a critical
illness are all attributed to persistent muscle weakness.2 Muscle weakness associated with critical
illness cannot be explained by immobility alone. The inflammatory response resulting from the
physiologic stressors of critical illness has been identified as a major contributor.3,4 The
inflammatory cascade of events that occurs consequent to critical illness has wide-reaching
effects, well beyond the organ system affected by the illness, and muscle is only one organ of
many that are affected.4 Inflammation diminishes both muscle mass and strength. Inflamed
muscle is problematic in that it can prolong need for mechanical ventilation, extend hospital stay,
and complicate recovery, as well as negatively impact quality of life for the individual with
critical illness.5
Mobilization is a progressive, interdisciplinary, goal-directed therapy that has been
proposed as one approach to mitigate the muscle weakness after a critical illness.6-8 Mobilization
is thought to improve blood flow, stimulate anti-inflammatory cytokine production and enhance
insulin activity and glucose uptake in muscle,4,9 all of which may serve to preserve muscle
strength and mass. Physical activity is also thought to reduce pain, decrease anxiety, improve
delirium, promote sleep, and improve mood, all of which are beneficial in reducing effects of
illness on muscle.10,11 Recent studies have documented improvements in functional status and
fewer ventilator and hospital days when mobilization was implemented into the plan of care.12,13
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Although mobilization is quickly being incorporated into care for critically ill patients, standards
for mobilization interventions are lacking. A critical analysis of current literature on mobilization
in the critical care setting was conducted, with a focus on what constitutes mobilization, which
patients should receive it and when, and who should provide these interventions. Results from
this analysis may be used to develop evidence-based interventions in the future as well as direct
research for mobilization interventions in critically ill patients.

Review of the Literature
A search of the literature was conducted using the search terms, mobilization, exercise,
activity, and critical illness to identify studies that evaluated mobilization interventions in
critically ill patients. Table 1 provides operational definitions for these terms.

Table 1. Operational Definitions.
Term
Mobilization
Activity
Exercise

Critical illness

Operational Definition
A goal-directed interdisciplinary therapy that involves a variety of
activities (on a continuum from passive to progressively active activities).
Movement in a patient initiated by the patient or an individual other than
the patient, and without active resistance.
Movement in a patient with a specified duration, intensity and frequency.
Passive exercise without resistance, initiated by an individual other than
the patient may include passive range of motion, passive cycle
ergometry, and neuromuscular electrical stimulation. Active exercise,
initiated by the patient or an individual other than the patient, may
include active range of motion, sitting, standing, active cycling and
walking.
Illness of sufficient severity that requires mechanical ventilation and/or
care in an intensive care unit.

14

CINAHL, MEDLINE, the Cochrane Database of Systematic Reviews, and PubMed
databases were examined from 1990 to 2012. Studies published from 1990 forward were
considered in an effort to reflect current practices; 170 articles were identified that met search
criteria. To be included in the final review, articles met the following criteria: 1) published in the
English language, and 2) incorporated mobilization as an intervention in a critically ill (acute or
chronic) sample, or 3) evaluated practitioner mobilization practices. Articles excluded from the
review were those that were reviews only (109 excluded), addressed mobilization after resolution
of the critical illness (29 excluded), were non-interventional studies (5 excluded) or written in a
language other than English (12 excluded). Upon selection, articles were reviewed for
descriptions of mobilization interventions, inclusion and exclusion criteria; when those
interventions were implemented within the patient’s illness trajectory; and which practitioners
were involved in the implementation. Fifteen articles were found that met inclusion criteria for
this review. Table 2 summarizes evidence found in the 15 articles.
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Table 2. Summary of Mobilization in Critical Care Evidence.
Authors

Bailey,
Thomsen,
Spuhler, Blair,
Jewkes,
Bezdjian, et al.,
2007

Purpose

Inclusion,
Sample Size

Exclusion

Timing

Intervention

Safety
Measures

Determine
whether physical
activity was safe,
feasible in resp.
failure patients

103, M>F, 63
years mean age;
48% > 65 yrs of
age
Required MV for
>4 days
Responding to
verbal stimuli
FiO2 < .6, PEEP
< 10 cmH20
(relative)
Absence of
orthostatic
hypotension
No
catecholamine
drips (relative)
20 (13 before
extubation, 7
after)
MV > 2 days,
ICU at least 7
days

Required MV for
<4 days,
Coma

Stabilization
through ICU stay
(mean time to
dangle 6.6+5.5
days; sit
11.3+10.1 days;
walk 12.4+10.7
days)
Twice daily
intervention

Pre and post 30
assist-control
rest period
Increased .2 FiO2
before activity
Progressive
dangle, sit,
ambulate

O2 saturation (>
80%)
BP (systolic 90200 mmHg)

Adverse events
Ventilator data
Hospital
disposition

Agitation,
confusion,
comatose;
SBP < 90;
vasopressors;
paO2/FiO2 ratio
< 200; paCO2 >
50; pH < 7.2;
CRRT; IV
sedation

Twice daily
intervention
beginning mean
day 5

Chair sitting, tilt
table, walking
(mean durations
were 150 min,
15 min, and 10
min
respectively)

HR (<130 or
within 20% or
baseline);
RR (<35 or
within 20% of
baseline); O2
saturation
(>88%); SBP
(>90 or <180)

Adverse events

90, mean age 59
years

Cardiorespirator
y instability

Day 5 or longer
Randomized to

Passive activity
to ambulation in

HR (>70% PM
or > decrease),

SF 36
6MWD

Bourdin,
To determine
Barbier, Burle, whether early
Durante,
activity in
Passant, et al., critical care
2010
setting is feasible
and safe, and
potential benefits

Burtin, Clerckx, To determine
Robbeets,
whether early

16

Outcome
Measures

Statistically
Significant
Outcomes
17% died; 33%
home
Duration MV
18.7+15.4 days
ICU LOS
22.7+15.9 days
Hospital LOS
26.6+17 days
No difference in
>65 vs < 65
Adverse events
occurred in .96%
of activity
events; did not
prolong stay or
increase costs
MV mean
duration 7 days;
ICU LOS 17
days
Improved O2
saturation with
chair sitting
Adverse events
in 3%; no
clinical
consequences
Decreased O2
saturation

Comments

2.4% unable to
tolerate activity
at all
12% unable to
complete some
scheduled
activities
Did not require
increased
staffing
Concluded to be
safe and feasible
No control group

43% were unable
to receive
interventions as
scheduled
Understaffing
limited second
episode during
the day

Drop outs older
Sedation and

Authors

Purpose

Inclusion,
Sample Size

Ferdinande,
passive exercise
Langer, et al., can improve
2009
function in
critically ill
compared to
physical therapy

Eligibility
determined by
intensivist
Anticipated MV
> 7 days
(only 15% of
prolonged MV
eligible)

Garzon-Serrano,
Ryan, Waak,
Hirschberg ,
Tully, Bittner,
Chipman,
Schmidt,
Kasotakis,
Benjamin,
Zafonte,

63; 232
mobilization
events; all
consecutive
patients were
included

To evaluate
whether
mobilization
practices differed
between nurses
and physical
therapists

Exclusion

None (in order to
not limit
mobilization
attempts, a phase
O category was
used)

Timing

Intervention

Safety
Measures

Outcome
Measures

control or
treatment
Mean enrollment
day 10 in control
group and day 14
in cycling group
Daily
intervention

both groups
Additional
cycling 20
minutes, 20
cycles/min;
increased
resistance if
active (55%
passive on
initiation; 13%
unable to
progress to
active)

SBP (>180 or >
20% decrease),
DBP (> 20%
decrease), O2
saturation
(<90%), RR
Parameters
normalized
within 2 minutes

Quad Force Berg
Scale
Weaning Time
LOS
1 year mortality

On admission

A progressive
mobilization
protocol

Continuous
monitoring BP,
HR, O2
saturation;
clinician
discretion for
phase 0

Phase (type) of
mobilization;
number of
adverse events;
barriers to
mobilization

17

Statistically
Significant
Outcomes
1.3+1.7%
16 sessions
terminated early
due to adverse
events
Treatment group
had farther
6MWD (196 m
vs 143 m:
p<.05), higher
SF- 36 (21 vs 15;
p<.01), greater
quad force 1.83
vs 2.37; p=.002)
Hand grip force
and Berg scale
not different
Weaning time,
LOS ICU, LOS
Hospital, and
one-year
mortality not
different
Nurses
mobilized earlier
than physical
therapists;
physical
therapists
mobilized to a
greater extent
(more active);

Comments

NMB greater
and LOS prior
to inclusion
longer in
treatment group
No clinical
physiologic
changes during
cycling
More patients
discharged home

Avoid strict
exclusion criteria
for mobilization;
capitalize on
different team
member
contributions

Authors

Purpose

Inclusion,
Sample Size

Exclusion

Timing

Intervention

Safety
Measures

Outcome
Measures

Eikermann, 2011

Griffiths.
Palmer,
Helliwell,
MacLennan,
MacMillan, 1995

To examine
whether PROM
can prevent
muscle wasting

5; MV with
NMB for 7 days

MV and NMB

Time from
intubation to
beginning of
therapy not
specified; 3x
daily while in
ICU

Three 3-hour
PROM
treatments daily
per CPM
machine on one
leg; SOC to
other leg; leg
randomized

NA

Muscle biopsy;
limb weight

Morris, Goad,
Thompson,
Taylor, Harry, et
al., 2008

To identify
frequency of
patients
receiving PT,
site of therapy,
and patient
outcomes

330; 48 hours of
intubation with
MV, 72 hours of
admission to
ICU

Inability to walk
or nonverbal
prior to
admission,
immune
compromise,
NM disease,
stroke, BMI >45,
unstable fracture,
DNR, cancer
therapy within 6
months, ICU
readmission
within 30 days,

Daily
intervention
beginning within
48 hrs of
intubation; actual
timing of
intervention start
not reported

Block allocation
design; 3 ICUs
serving as
control and
treatment unit at
different times
PT as ordered
daily (control) vs
mobility
protocol with
progressive
additive
advance from
PROM to active

O2 saturation
>88%, MAP >65

Survivors to
discharge who
received PT;
days until OOB;
ventilator days;
ICU LOS;
hospital LOS

18

Statistically
Significant
Outcomes
identified
barriers differed
between groups;
nursing severity
score predicted
mobilization
Fiber area
slightly
increased in
treated leg (mean
increase 11%);
less protein loss
in treated leg;
treated leg
weighed
significantly
more than
untreated leg
2.3% of events
not initiated due
to instability
47% of usual are
group received
PT while 80%
received PT with
mobility protocol
(treatment group
received more
therapy, p<.001);
treatment group
OOB earlier (5.0
days vs 11.3

Comments

PROM preserves
muscle
architecture but
may not prevent
wasting

Standardized
approach
Only survivors
included in data
analysis
No effect from
steroids
Average cost per
patient less but
not statistically
significant

Authors

Purpose

Inclusion,
Sample Size

Exclusion

Timing

new arrhythmia
cardiac ischemia

Pohlman,
Schweickert,
Pohlman, Nigos,
Pawlik, et al.,
2010

To determine
feasibility of a
protocol of early
therapy and
sedation
interruption in
mechanically
ventilated
critically ill
patients; to
identify adverse
effects and
barriers

49; age >18
years; MV < 72
hrs but expected
at least an
additional 24
hrs; Barthel
Index >70 before
admission

Rapidly evolving
neuromuscular
disease; cardiac
arrest;
irreversible
condition;
increased ICP;
absent limbs;
involvement in
another trial

Intervention

Safety
Measures

Outcome
Measures

MAP<65;
HR<40, >130;
RR<5, >40; O2
saturation <88%;
increased ICP;
active GI bleed;
active
myocardial
ischemia;
insecure airway;
device
dislocation

Number and
duration of
therapy sessions,
types of activity
Potential barriers
to therapy
Neurocognitive
measures

transfer
(treatment)

Within 72 hrs of
intubation; time
from intubation
to intervention
1.5 days (1.02.1)

Daily
interruption of
sedation with
therapy during
that time; PT/OT
screen; PROM
of seven sets of
joints (number of
repetitions or
duration not
specified);
progressed to
sitting, standing,
walking as
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Statistically
Significant
Outcomes
days; p<.001);
26.7% unable to
progress beyond
PROM; 7.1
mean days at
PROM level
No significant
difference in
ventilator days
ICU LOS shorter
for treatment
group (5.5 vs
6.9; p=.025);
hospital LOS
shorter for
treatment group
(11.2 vs 14.5;
p=.006)
Therapy
occurred on 87%
of days of study,
90% of days on
MV; 81% of
days post-ICU;
duration 26+14
mins while on
MV, 28+10 mins
while in ICU,
28+10 post-ICU;
85% able to
perform AROM;
69% dangled;

Comments

Enrolled 49
participants over
26 months
Unsure as to use
of CAM-ICU; no
analysis reported

Authors

Purpose

Inclusion,
Sample Size

Exclusion

Timing

Intervention

Safety
Measures

Outcome
Measures

Statistically
Significant
Outcomes
33% up to chair;
15% walked
Potential barriers
to therapy did
not prevent
therapy
Adverse events
occurred in 16%
of all sessions
(498) but all
resolved after
stopping therapy
CAM-ICU was
negative in 40%
of patients and
positive in 53%
of patients

Comments

MAP<65 or
>110; systolic
BP >200;
HR<40 or >130;
; RR<5, >40;
pulse ox <88%;
increased ICP;
active GI bleed;
active
myocardial
ischemia;
insecure airway;
ventilator
asynchrony; new

Functional status
at discharge
Number of
hospital days
with delirium
(CAM-ICU)
Number of
ventilator-free
days during
hospital stay;
length of ICU
stay
Adverse events

50% achieved
functional
independence at
discharge
(Barthel >70),
59% in protocol
group and 35%
in control
(p=.02)
In protocol
group: less
delirium (2.0 vs
4.0, p=.03);
more ventilator-

Death assigned 0
ventilator-free
days
ICU stay
approached
significance in
protocol group
(p=.08); hospital
LOS
nonsignificant

tolerated

Schweickert,
Pohlman,
Pohlman, Nigos,
Pawlik, et al.,
2009

To determine
whether an early
therapy protocol
combined with
sedation
interruption
improved
functional and
neuropsychiatric
outcomes

104; age >18
years; MV < 72
hrs but expected
at least an
additional 24
hrs; Barthel
Index >70 before
admission

Rapidly evolving
neuromuscular
disease; cardiac
arrest;
irreversible
condition;
increased ICP;
absent limbs;
involvement in
another trial

Within 72 hrs of
intubation; time
from intubation
to intervention
1.5 days (1.02.1)

Randomization
to SOC or
protocol; daily
interruption of
sedation with
therapy during
that time; PT/OT
screen; PROM
of seven sets of
joints (number of
repetitions or
duration not
specified);
progressed to
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Authors

Skinner, Berney,
Warrillow,
Denehy, 2008

Purpose

To identify
exercise
prescription by
PTs for MV
patients and
outcome
measures
commonly used

Inclusion,
Sample Size

111; PTs
working in ICUs
in Australia; no
returns from one
region

Exclusion

NA

Timing

NA

Intervention

Safety
Measures

sitting, standing,
walking as
tolerated

arrhythmia

NA- 24-item
survey of PT
practices in ICUs
(response rate
75%)

PTs identified
O2 saturation,
HR, RR, and
perception of
fatigue as safety
measures
necessary

21

Outcome
Measures

Only 34% used
outcome
measures; RR,
O2 saturation,
distance walked
were used

Statistically
Significant
Outcomes
free days (23.5
vs 21.1; p=.05);
therapy began at
1.5 days in
protocol group
and 7.4 days in
SOC group;
sedation and
analgesia the
same between
groups
One desaturation
episode in 498
events
94% of
respondents
prescribed PT
regularly; 42%
indicated that PT
should be
performed in all
ICU patients
except for those
on inotropes,
CRRT, ARDS;
5% thought PT
should be
restricted to
those on MV;
frequency varied
widely; type of
activity was

Comments

Even
experienced
practitioners
have widely
variable
practices;
evidence not
applied to
practice

Authors

Purpose

Inclusion,
Sample Size

Exclusion

Timing

Intervention

Safety
Measures

Outcome
Measures

Stiller, Phillips ,
& Lambert, 2004

To determine
hemodynamic
and respiratory
response to
mobilization of
the critically ill
patient

31 participants
receiving 69
treatments; HR
<50% APN;
O2saturation
>90%;
paO2/FiO2> 300

PROM and
mechanical
transfers
excluded;
extensive
exclusion criteria
based on medical
condition

3 different time
periods to
maximize
variability; mean
29 days of
intubation at
onset of therapy

Progressive
mobilization
from dangle to
ambulation;

HR; HR APN;
systolic and
diastolic BP; O2
saturation;
patient
appearance

Number and type
of therapies;
change in HR,
BP, and O2
saturation from
baseline

Stockley,
Hughes, &
Rooney, 2010

To determine PT
passive ROM
practices in ICUs
in the UK

165, 152 of
which reported
using PROM in
MV ICU
patients;
participants

Not working
with ICU
patients

NA

12-item
questionnaire;
open ended,
closed and
matrix questions

Monitoring
parameters used
were ICP, PAC,
CVP, RR,
HR/rhythm, BP
O2 saturation

Frequencies of
therapies
performed and
safety
parameters
routinely
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Statistically
Significant
Outcomes
ROM, sit to
stand, transfer,
march, ambulate,
tilt table;
multiple factors
were used to
determine
ability,
frequency and
duration;
HR and BP
significantly
increased with
mobility
(p<.001)
increased but not
clinically
significant;
decreases in O2
saturation
evident but not
significant
(p=.44); 3
desaturation
events required
intervention
PROM
performed by all
study
respondents
daily; mean 5
repetitions per

Comments

19% of patients
in the ICU
received this
intervention;
83.8% received
ROM

Purposes for
PROM may
differ amongst
diagnostic
groups;
monitoring is

Authors

Purpose

Inclusion,
Sample Size

Exclusion

Timing

Intervention

Safety
Measures

registered to
National Health
Service
Return rate 67%

Thelandersson,
Cider,
Volkmann, 2010

To determine if
PROM had an
impact on
intracranial,
cerebrovascular,
and
hemodynamic
parameters

12 brain injured
participants in
neuro ICU; MV;
IV or
parenchymal
catheter; arterial
catheter in place;
inability to move
limbs actively

Outcome
Measures
monitored by
respondents

Fracture or other
problem
preventing
PROM

Measures every
minute for 10
min before,
during PROM
and at rest for 10
min

PROM by PT in
defined position;
7 times in same
order to UE/LE
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ICP, BP, MAP,
HR, O2
saturation

TCD; ICP; BP;
MAP; HR;
pulsatility index

Statistically
Significant
Outcomes
joint (1-20); on
both UE and LE;
single joint
movements

In treatment
group: No
significant
difference at any
time point
between HR, BP,
and CPP
measures except
for PI increased
(p<.01); ICP was
significantly
lower after
exercise (p<.01)
In control group:
MAP, and
systolic BP
showed
significant
decreases after

Comments

essential
component of
therapy but
monitoring
guidelines not
specified; longer
duration and
increased
frequency
needed to
prevent changes
in muscle
architecture
Used age and
gender matched
healthy control
group
Concluded
PROM was safe

Authors

Purpose

Inclusion,
Sample Size

Exclusion

Timing

Intervention

Wiles & Stiller,
2009

To investigate
PROM practices
among
Australian PTs

51; PTs working
in Level 3 ICUs
in Australia

NA

NA

42-item
questionnaire;
closed end or
semantic rating

NA

NA

Winkelman,
Higgins, &
Chen, 2005

To describe
typical
therapeutic
activity in MV
critically ill

20; physiologic
stability; MV in
critical care
setting

Quadriplegia and
stroke; recent
surgery

5-15 days after
intubation (mean
day 10)

Observational
study, 8 hours

NA

Motor
Assessment and
Activity Scale
Actigraphy
measured

24

Safety
Measures

Outcome
Measures

Statistically
Significant
Outcomes
PROM (p<.01);
no between
group
hemodynamic or
cerebrovascular
differences; no
within group
differences in
cerebrovascular
parameters
86.3% had
standing PT
orders;13.7%
required referral;
only 13.7%
performed daily
passive ROM;
most common
technique used
was manual, but
other techniques
were used and
varied widely;
aims of
treatment
influenced
choice of method
Most common
activities were
turning an
PROM; 73% of
therapeutic

Comments

PTs taught
family to
perform ROM or
nurses performed
it; PTs believed
nurses did not
perform PROM
without
direction;
medical data
dictated
decision about
treatment

Placement of
actigraphy
device critical;
actigraphy
device records

Authors

Purpose

Inclusion,
Sample Size

Exclusion

Timing

Intervention

Safety
Measures

patients; to
compare two
activity measures

Winkelman,
2010

Exploration of
types and
duration of
activity;
feasibility of
analyzing serum
(test the
procedure in
advance of a
larger study)

Outcome
Measures
activity

17; Medical ICU
or stepdown;
COPD
exacerbation;
paO2/FiO2 100400; FiO2<.6

(see inclusion
criteria)

First observation
48-60 hrs after
unit admission;
standardized
time between
10a and 2p; 2
days of
observation

60 minutes of
rest prior to
activity, 20
minutes planned
activity, 10
minutes data
collection;
activity provided
by nurse; serum
collection
immediately
following rest
and then activity
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Vital signs,
O2 saturation

Activity duration
(actigraph)

Statistically
Significant
Outcomes
activities
initiated by
nurse; 11
minutes of
activity
experienced
during turning
and 8 minutes
for PROM per 8
activity was
infrequent and of
short duration
Mean duration of
activity 18.8
minutes day 1,
20 minutes day
2; activity counts
indicated low
levels of activity;
no difference
between
cytokine levels
at rest or after
activity; IL-6
decreased on day
2, IL-10
increased on day
2; O2 saturation
was within 2%
of baseline, HR,
BP, RR within
20% of baseline

Comments

more than
observed;
precision a
concern; no
measure of
activity intensity

Large sample
size necessary to
determine impact
of low level
activity on
inflammation
(data used to
calculate sample
size for future
studies)

Legend: APN=age predicted norm; ARDS=acute respiratory distress syndrome; AROM=active range of motion; BMI=body mass index; CAM-ICU=Confusion Assessment Method-Intensive Care Unit;
COPD=chronic obstructive pulmonary disease; CRRT=continuous renal replacement therapy; CVP=central venous pressure; DBP=diastolic blood pressure; DNR=do not resuscitate; F=female; FiO 2=fraction of
inspired oxygen; GI=gastrointestinal; HR=heart rate; hrs=hours; ICP=intracranial pressure; ICU=intensive care unit; IV=intravenous; LE=lower extremity; LOS=length of stay; M=male; MAP=mean arterial
pressure; MV=mechanical ventilation; NA=not applicable; NM=neuromuscular; NMB=neuromuscular blockade; OOB=out of bed; OT=occupational therapy; O2=oxygen; PAC=pulmonary artery catheter;
paO2=partial arterial oxygen pressure; paCO2=partial arterial carbon dioxide pressure; PEEP=positive end expiratory pressure; PI=pulsatility index; PM=predicted maximum; PROM=passive range of motion;
PT=physical therapy; RR=respiratory rate; SBP=systolic blood pressure; SOC=standard of care; TCD=transcranial Doppler; UE=upper extremity; UK=United Kingdom; 6MWD=six minute walk distance
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Findings
What Constitutes Mobilization?
Mobilization was found to cover a wide range of practitioner-delivered progressive
activities, from passive and active range of motion (ROM), to dangling, standing or lift transfer
to a chair, and ambulation.13-15 Range of motion was the most commonly applied mobilization
intervention,16-17 but actual ROM practices were found to vary widely in duration and intensity
amongst studies. Schweickert, et al.13 utilized 10 repetitions per joint in their study, while
Thelandersson, Cider, and Volkmann18 used 7 repetitions per joint, and Morris, et al.19 used 5
repetitions per joint. No rationales were provided for these choices. Wiles and Stiller20 identified
2-30 (mean=13) repetitions per joint in their survey of Australian physical therapist practices in
intensive care units, while Stockley, Hughes, Morrison, and Rooney21 reported 1-20 (mean 5)
repetitions per joint in their study of physical therapist practices in the United Kingdom.
Intensity, which constitutes partial to full stretch, was reported by therapists to also vary widely
in both studies. All five studies reported provision of ROM to both upper and lower limbs.
In an attempt to provide ROM in a more standardized manner and meet prescriptive
guidelines (frequency, duration and intensity of therapy), mechanical devices have been used to
provide upper and lower extremity passive and active exercise. Devices used include continuous
passive motion machines and cycle ergometers. Griffiths, et al.22 found that three hours of
passive movement daily in one leg of 5 critically ill patients increased muscle fiber and weight in
the treated leg as compared to the untreated leg. Richard, Staley and Miller23 used a continuous
passive motion machine in the upper and lower extremities of critically ill burn patients, while
Burtin, et al.24 used a cycle ergometer for passive leg exercise in two 10 minute bouts, 20
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cycles/minute in mechanically ventilated critically ill patients. This device also allowed
participants to progress to active cycling as their condition improved. Additional devices found
in the literature included use of a tilt table for weight bearing25 and electrical stimulation of
muscle contraction.11, 26, 27
More active and aggressive approaches to mobilization have been recently advocated,
particularly in mechanically ventilated critically ill adults,13, 28 and protocols have been used to
specify step-wise succession of activity. Morris, et al.19 described a mobilization protocol that
consisted of a four-step approach which began with passive range of motion (PROM), then
progressed to active range of motion, then sitting, and then transfer. Another began with sitting
and progressed to ambulation.10 Pohlman, et al.12 presented an algorithm to guide progression
from passive ROM to ambulation, while Schweickert, et al.13 present a protocol that ranged from
active ROM to ambulation. Protocols were noted to vary in their start and end points, but central
activities (active range of motion, sitting, and transfer out of bed) were consistent. More recently,
Hanekom, et al.29 described development of a clinical mobilization algorithm developed by a 3round Delphi process. However, the algorithm for unresponsive patients addressed only position
changes while in bed, head of bed elevation, and daily passive range of motion as appropriate
interventions, which may be insufficient for this population. While the consensus was significant
(94%), less than 50% of statements were rated as essential, indicating provider disagreement
about optimum approaches to mobilization. Further, Delphi participants were therapists and did
not include other bedside practitioners such as nurses.
Many participants in each of these studies were unable to progress to the protocol end
point. Morris, et al.19 found that participants remained in the passive ROM stage of therapy for
7.1 days before progressing to more active exercise, and 44(26.7%) of participants in a
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progressive mobility study were not able to progress further than passive ROM. Reasons were
decreased responsiveness and physiologic instability. Pohlman, et al.12 incorporated a
mobilization protocol that began with active therapy, and found that even when participants
(N=49) were able to perform active range of motion upon study entry, 13% were unable to
participate in ongoing therapy sessions because of physiologic instability, and were reduced to
passive activity only. Bailey, et al.10 initiated activity only after sedatives and catecholamines
were discontinued, and when patients were deemed to be physiologically stable. Ambulation still
comprised only 42% of all activity events.

Who Should be Mobilized?
Study samples in this review varied widely (Table 2) but participants commonly had
respiratory failure and were mechanically ventilated, in addition to other comorbidities.
Recognizing the severity of critical illness as a significant factor in potential muscle weakness,
inclusion criteria often addressed the anticipated need for mechanical ventilation for at least 48
hours.10,12,13,19, 30 Stable respiratory status was also identified as an inclusion criteria, described as
FiO2 < .6 and PEEP < 10 cm H2O. Heart rate, blood pressure and oxygen saturation within unitspecified norms were common inclusion criteria. Although physical therapists usually consider
cardiac reserve as an indicator for activity tolerance, little mention was made of those measures
as being useful in guiding who to mobilize. Several studies included patients on vasoactive
infusions or neuromuscular blockade,15,22 while others excluded such participants.12,13 The wide
variation in mobilization study inclusion criteria suggests that clinician assessment is a critical
component in deciding which patients should be mobilized. Lack of clearly defined evidence-

29

based protocols or algorithms leaves clinicians with broad leeway in who receives
mobilization interventions.
The population of patients excluded from these studies warrants additional discussion. In
the study by Stiller, Phillips and Lambert,15 participants comprised only 19% of the total ICU
population during the study. Exclusions were made on the basis of level of consciousness and
cardiovascular or respiratory instability. Schweickert, et al.13 excluded those with frequent
desaturation, hypotension, new cardiac enzyme changes, new antidysrhythmic therapy, or recent
ventilation mode change until those problems resolved. Additional exclusion criteria were:
immunocompromise, cancer therapy, body mass index (BMI) > 45, greater than 72 hours of
admission before intubation, non-ambulatory prior to admission, or do not resuscitate
(DNR) status. The number of those excluded was not provided. Morris, et al.19 excluded those
with increased intracranial pressure, neuromuscular disease, cardiac arrest, absent limbs or an
irreversible disorder, and Bailey, et al.10 excluded any unresponsive patient. While the rationale
for exclusion of some of these participants is logical, there is no empirical evidence to
support many of the reasons for avoiding mobilization. Those excluded represent a
substantial portion of the critically ill population, perhaps signaling important opportunities to
improve outcomes.

When Should Mobilization be Started?
Optimum timing to initiate mobilization and duration of mobilization interventions is not
clear in the literature, and patient condition alone does not appear to be the determining factor. A
significant concern is that practitioners may perceive that mobilization is too difficult given the
equipment or patient inability to participate, or it may be inappropriate due to concerns about
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mobilization worsening physiologic instability.11 Loss of muscle mass and strength is evident
soon after critical illness onset; 2% of mass may be lost within the first 24 hours of critical illness
and this loss can progress exponentially.31 Since muscle changes appear soon after onset of
critical illness,32 it is logical to consider implementation of mobilization soon after illness onset.
Yet, mobilization is often delayed until physical stability is evident, often after an acute phase of
illness,33 and delay may add to disability.7
Early mobilization is a term that has recently appeared in literature, denoting
mobilization activities begun in the critical phase of illness. Several investigators have
demonstrated that it is feasible to implement mobilization soon after critical illness onset.
Pohlman, et al.12 were able to institute mobilization in a mean 1.5 days after intubation, while
Winkelman14 enrolled patients within 48 hours of intubation, and Schweickert, et al.13 enrolled
participants within 72 hours of intubation. Although Burtin, et al.24 identified their study as
“early,” participants were not considered for study entry before day 5 after intubation. However,
even at 5 days, patients were mobilized sooner than the standard of care. Criteria to document
readiness to institute mobilization have not yet been developed and require further exploration.
Tolerance of passive exercise may be one signal that progression is appropriate.
As a therapy, mobilization requires evidence-based descriptions of duration, intensity,
and frequency, but limited evidence was found regarding these parameters in the literature.
Using direct observation and actigraphic measurement of activity, Winkelman, Higgins and
Chen17 documented 11 minutes of activity over an 8 hour period. In a subsequent study of 17
mechanically ventilated patients with COPD, Winkelman14 was able to sustain progressive
mobilization activities for 20 minutes, while Pohlman, et al.12 found the mean duration of active
therapy at 26 + 14 minutes in their study of active exercise interventions. Burtin et al.24 were able
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to add an additional 20 minutes of passive activity to their current mobilization protocol.
Intensity is implied through progression, and has consistently been left up to the discretion of the
practitioner, with clinical recognition of tolerance used as the progression decision point (but not
specified). Daily frequency of therapy was the norm in studies,10,12,13,14,20 except for one study
that reported passive ROM three times a day.19 Although no rationale for the daily therapy was
found, the daily routine was most likely reflective of physical therapy rather than nursing
practices.
As a goal-directed therapy, the primary purpose of mobilization is to improve patient
outcomes. This implies the need to continue mobilization interventions until measureable end
points. Both short and long term outcomes have been reported in the literature. In a study of 330
intubated patients in seven intensive care units (ICUs) in one hospital in North Carolina, Morris
et al.19 demonstrated improved outcomes in participants who received a mobilization protocol
(N=165) as compared to those who received standard of care (SOC; N=165). A mobility team,
consisting of a critical care nurse, nursing assistant (NA) and physical therapist (PT), delivered
the mobilization protocol to participants who met criteria. The mobility protocol was started as
soon as possible after admission, and continued daily throughout the ICU stay. Those receiving
SOC received physical therapy per physician order or passive range of motion per nursing unit
protocol (specified as “prn”). The team was assigned to one of the seven units on a monthly
rotating basis, and geographic location of the patient determined whether they received SOC or
the intervention. Although ventilator days did not differ among the two groups, the mobilization
protocol group was out of bed sooner (5 vs 11.3 days, p<.001), had a shorter length of ICU stay
(5.5 days vs 6.9 days, p=.02), and shorter length of hospital stay (11.2 vs 14.5 days, p=.006).

32

Similarly, Schweickert, et al.13 studied 104 critically ill mechanically ventilated patients
from two academic medical centers that underwent daily interruption of sedation and
mobilization. Using a computer-generated randomization scheme, participants were randomized
to either SOC or a mobilization intervention; both groups received daily sedation interruption.
The standard of care group (N=55) received physical therapy only as ordered by the physician.
The intervention group (N=49) received daily passive range of motion, 10 times to each joint by
a physical or occupational therapist. If the patient was able to interact, active-assisted and active
range of motion (AROM) were added. If AROM was tolerated, then physical therapists began
activities that progressed from sitting, to transfer, exercise in preparation for walking, and
walking. The intervention group received significantly more therapy than the control group
(p<.0001), and received therapy earlier (1.5 days vs 7.4 days, p<.0001). Only three patients in
the SOC group progressed to ambulation while 12 patients in the intervention group progressed
to ambulation. Although no significant differences were found in ICU or hospital lengths of stay
between groups, the intervention group had higher functional status scores (p=.02), higher
Barthel Index scores (p=.05), a higher number of independent ADLs (p=.06), and greater
walking distance (p=.004) at hospital discharge than the SOC group. These findings are
important in spite of the failure to impact length of stay data, as they may translate into lower
costs for after hospital care and improved quality of life. After 5 days of intubation, Burtin, et
al.24 instituted a passive cycling protocol in addition to ROM and progressive mobility. In spite
of the delay in mobilization, patients who received passive cycling had significantly better
exercise tolerance (p < .05), increased muscle force (p< .01), and improved perception of
functional capacity (p < .05) upon discharge as compared to those who did not receive cycling
therapy. Exercise-induced decreases in inflammation were postulated as one reason for the
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treatment group outcomes. Whether a decrease in inflammation could be directly attributed
to activity and improved outcomes is not yet known, but preliminary evidence suggests
that cytokine profiles in critically ill patients may be improved by 20 minutes of sustained
daily activity.14
In spite of mounting evidence that mobilization improves outcomes, providers remain
reluctant to order mobilization, citing safety concerns. Finding no empiric support for safety of
mobilization in the critical care setting, Stiller, Phillips, and Lambert15 attempted to demonstrate
that progressive mobilization was safe in critically ill patients in Australia. Thirty-one patients
that were prescribed mobilization therapy as part of their care were included; they were enrolled
in the study over three separate two week time periods to maximize population diversity, and
most (78%) were mechanically ventilated. The 31 participants underwent 69 mobilization events
during the study. Mobilization consisted of progressive activities that moved from lying to
sitting, transfer and walking; only one patient progressed to walking. Safety measures assessed
were those readily available at the bedside, and included heart rate (HR), systolic and diastolic
blood pressure (BP), and oxygen saturation (SpO2). Oxygenation and respiratory reserve were
calculated from available physiologic data. Safety measures were assessed immediately prior to
mobilization, upon completion of the therapy, and after one minute of rest. Prior to mobilization,
91.3% of participants had evidence of limited (but not severely compromised) cardiac or
respiratory reserve. Both HR (p<.001) and BP (p<.001) were significantly increased during
mobilization as compared to the baseline, but these increases were not deemed to be
clinically significant nor did the changes require the intervention to be stopped. Of the 69
mobilization events, three events were associated with desaturation and required intervention;
baseline SpO2 was considered the limiting factor but the sample size was too small to allow
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prediction. The authors concluded that mobilization was safe, even in the face of limited cardiac
and respiratory reserve. It is important to note that mobilization was started in this study at a
mean of 29 + 19.6 days after admission indicating that the mobilization therapies were
implemented during a less critical phase of illness, perhaps at a time where participants had
already developed substantial deconditioning and muscle weakness. Morris, et al.19 enrolled
study participants and began mobilization within 48 hours of intensive care admission; 44
(26.7%) of the intervention participants did not progress beyond the first mobility level (PROM)
but tolerated the intervention without incident. Sessions were withheld in only 1.4% of
participants due to blood pressure (BP) concerns and in 0.9% due to heart rate (HR) concerns.
Fatigue rather than vital sign change was cited as the most frequent reason for ending a therapy
session, and these findings led the authors to conclude that early mobilization was safe.
Schweickert, et al.13 began mobilization on study participants within 72 hours of intubation, and
used standard unit blood pressure (<65 MAP or >110 MAP, or BP > 220 systolic), heart rate
(<40 and >130), and oxygen saturation (<88%) parameters for provider notification as the
guidelines for holding or stopping mobilization. Mobilization was stopped in 4% of participants
in response to ventilator dyssynchrony, and only one episode of desaturation was noted,
supporting the safety of mobilization within 72 hours of intubation. When mobilizing patients to
the chair and ambulation after 5 days of intubation, Bailey, et al.10 encountered only 14 adverse
events in 1440 episodes of activity (1%). None of the adverse events added additional length of
stay or cost. Commonly measured physiologic criteria served as safety measures and varied
across studies, as did parameters for stopping or hold mobilization activities. All authors mention
the need for ongoing safety assessments for any mobilization intervention. Limited information
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was available on physiologic effects of passive activity alone, especially in patients with
cardiopulmonary compromise.
Concern has been expressed about early mobilization contributing to increased muscle
inflammation, which may actually compound rather than prevent muscle weakness.6 An increase
in inflammation in response to exercise may be measured via cytokine levels, specifically IL-6
and IL-10. Stability in cytokine levels would serve as a safety indicator for mobilization, while
decline in pro-inflammatory cytokine levels or improvement in pro- to anti-inflammatory ratios
would serve as an efficacy measure. Winkelman, Higgins and Chen17 demonstrated no
significant changes in cytokine levels with passive activity (< 15 min), suggesting that passive
activity does not increase inflammation. However, further study would add to safety support for
this intervention.
Physiologic instability in mechanically ventilated critically ill patients may persist for
days to weeks, delaying use of mobilization interventions. The loss of muscle soon after critical
illness onset suggests that muscle protective interventions should be started early in the course of
critical illness, probably within the first twenty-four hours. Passive exercise may be the most
appropriate activity for these patients in the early phase of illness.8 However, empirical evidence
supporting the safety or efficacy of passive activity was not found, particularly during periods of
physiologic instability. Further, prescriptive parameters for passive activity have not been
identified for this population.

Who Should Deliver Mobilization?
Several different practitioners, including nurses, nursing assistants, occupational
therapists and physical therapists delivered mobilization interventions in the studies
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reviewed.10,12,15,19,34 While physical therapists and nurses were integral to all protocols, the
protocols tended to be therapist-driven. Garzon-Serrano, et al.35 reported that physical therapists
mobilized patients at a higher level than nurses, and nurses more commonly used passive activity
while therapists performed more active interventions. In addition, barriers perceived by nurses
and therapists differed; nurses perceived hemodynamic instability and renal replacement therapy
(RRT) as the two most significant barriers while therapists perceived neurologic impairment as
the most significant barrier. Interestingly, no study has addressed whether hemodynamic
instability or presence of RRT are true barriers to mobilization, as these factors have been used
as exclusion criteria. Limited evidence exists that mobilization is appropriate for neurologically
impaired patients.18
Although underemphasized, a team approach to mobilization was noted to be universal
across studies. This could be due to the collaborative multidisciplinary approach that is more
common in critical care, or the complexity of clinical decision-making required in this setting.
Additionally, mobilizing a patient that may be unable to assist or that has a multitude of tubes,
lines, and drains requires many hands. Garzon-Serrano, et al.35 suggested that capitalizing on
different team member contributions could enhance overall mobilization in the critical care
setting. While mobilization is clearly within the scope of nursing practice, nursing involvement
in study protocols and reports was limited. Only six of the15 studies included nurses as authors;
three of those were primary authors. Nursing involvement was constrained to assessment,
implementation of passive activity only, or assistance with mobilization under the direction
of physical therapists.
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Discussion and Implications
Knowledge that supports decisions about how and when to mobilize critically ill patients
is evolving. Nurses and other bedside practitioners have a “toolbox” of mobilization activities
that can be used to progressively mobilize their patients, but the evidence supporting specific
mobilization approaches is limited. Treatment routine and starting and ending points varied
across studies, and even standard of care differed when randomization was used. With treatment
routines varying so widely, comparing study outcomes is challenging at best. Clinical trials that
incorporate progressive mobilization across broad populations of critically ill patients are
needed, along with studies that demonstrate benefit of creative approaches to mobilization at the
bedside.
Differing perceptions of what constituted adequate mobilization may have accounted for
protocol variations. Little attention was given to passive activity in the studies reviewed. This
may be due to the fact that passive therapies are not billable services for physical therapists, and
passive activity is often relegated to the realm of nursing care. However, it may be that passive
activity is the most appropriate initial mobilization activity for most critically ill patients. Passive
exercise can be delivered early in critical illness, but further study is needed to clarify the
optimum method, duration, and frequency. Criteria for patients who should be mobilized must
be broadened beyond the strict inclusion criteria for studies in this review, as many critically ill
patients may be unnecessarily denied this important intervention. Empirical evidence for those
who should not be mobilized requires further development as well.
Nurses and physical therapists differ in their approaches to mobilization. It is evident that
a team approach is required to implement mobilization protocols, and nurses are key members.
Nurse-driven protocols for early mobilization require further development, and team roles
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require further delineation. While nurses have many competing agendas that may limit ability to
implement mobilization activities, mobilization should not be solely within the realm of physical
therapy. Nurses must view mobilization from the perspective of a prescriptive therapy, and
address greater intensity, longer duration, and greater frequency concerns, especially with
passive activity.
Addressing practitioner perceived barriers to mobilization is necessary, particularly if the
perceived barriers are not supported by evidence. Perceived barriers represent opportunities for
education as well as research. Approaching mobilization as an interdisciplinary process may also
limit perceived barriers.36 Sedation is one important barrier to mobilization that has received
little attention in the studies reviewed. Limiting amount and duration of sedation, or providing a
“sedation vacation” may significantly impact the mobilization provided as well as improve
outcomes.35
Development of evidence-based clinical decision tools that can be implemented across
settings may facilitate implementation of mobilization protocols for critically ill patients. It is
beyond time to question whether mobilization is of benefit, but rather time to move toward
evidence that supports optimum approaches.
The rationale for why mobilization may be effective in improving outcomes from critical
illness deserves further attention. The current logic is that mobilization may diminish
inflammatory effects on muscle, but limited evidence exists supporting this logic. Inflammatory
markers may provide explanation for benefit of mobilization as well as indicators for those who
should not be mobilized.37 Additional benefits of mobilization also requires further exploration.
It could be that mobilization may decrease pain, anxiety, delirium, need for sedation, and even
insulin requirements. Reduction of these factors may provide some degree of muscle protection.
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Limitations to this review included the exclusion of non-English articles. Further,
substantial practice changes have occurred from the time of the earliest article reviewed (1994).
However, thirteen of the articles reviewed for this analysis appeared in literature from 2004
forward.

Summary
Immobility and inflammation weaken muscle in critically ill patients. Mobilization is
thought to produce physiologic effects that preserve muscle function. Several different and
progressive approaches to mobilization, beginning with passive range of motion, may be used,
with progression of activity based on patient tolerance. With muscle damage occurring early
after critical illness onset, early mobilization is advocated, but safety concerns abound. Passive
activity, if demonstrated to be safe, may provide early benefit to those critically ill patients who
are not yet able to tolerate progressive activity. Gaps in the literature are related to inconsistent
use of a mobilization techniques, lack of identification of optimum timing for initiation of
mobilization, and lack of inclusion of a population in great need of muscle protection. Further,
findings related to the inflammatory response to activity are contradictory, requiring further
exploration.
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CHAPTER 3: FINDINGS
Abstract
Muscle weakness is the most common and persistent problem after a critical illness. Early
mobilization of the critically ill patient, beginning with passive exercise and progressing to
ambulation, may mitigate muscle effects of the critical illness. However, mobilization may
produce adverse effects, especially early in the illness when risk for physiologic deterioration is
common. If safe, introducing a mobility intervention early in the illness may facilitate weaning,
shorten intensive care unit and hospitals stays, and improve quality of life for mechanically
ventilated critically ill patients.
The aim of this study was to assess the cardiopulmonary, neurodynamic, pain and
inflammatory responses to an early standardized passive exercise protocol (PEP) in mechanically
ventilated critically ill patients. Using a quasi-experimental within-subjects repeated measures
design, mechanically ventilated critically ill adults who were physiologically stable underwent a
single standardized passive exercise intervention within 72 hours of intubation. The intervention
consisted of 20 minutes of bilateral passive leg movement delivered by continuous passive
motion machines at a rate of 20 repetitions per minute, from 5-75 degrees, to simulate very slow
walking. Physiologic parameters evaluated included heart rate (HR), mean blood pressure
(MBP), oxygen saturation, intracranial pressure (ICP) and cytokine levels, obtained before,
during, and after the intervention. The Behavioral Pain Scale, administered before, during and
after the intervention was used as a measure of participant comfort.
The study sample was comprised of 18 (60%) males and 12 (40%) females, with a mean
age of 56.5 years (SD 16.9 years), who were primarily Caucasian (N=18, 64%). Mean APACHE
II scores for the sample were 23.8 (SD 6.2) with a mean predicted death rate of 48.8 (SD 19.8),
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indicating moderate mortality risk related to illness severity. Number of comorbidities ranged
from 1-10 (X=4). All participants completed the intervention with no adverse events. Using
repeated measures analysis of variance (rmANOVA), no significant differences were found in
heart rate, blood pressure, or oxygen saturation at any of the four time points in comparison to
baseline. Behavioral Pain Scale scores were significantly reduced (p=.02) at 10 and 20 minutes
after the PEP was started, and were sustained. IL-6 was significantly reduced (p=.03) at the end
of the intervention but not at the final time period. IL-10 values were not significantly different
at any of the three time points, but IL-6 to IL-10 ratios decreased significantly (p=.05) from Time
0 to Time 3, and Time 3 to Time 4.
Passive leg exercise was well tolerated. HR, MBP, and oxygen saturation were
maintained within unit specified range during and for one hour after activity, and patient comfort
improved during and after exercise. A downward trend in heart rate was noted in participants,
which is contrary to usual heart rate response during exercise, but may actually represent clinical
improvement in this population. Reduction of mean IL-6 values at Time 3 but not Time 4
suggests that the PEP was responsible for the improvement. Improvement of IL-6 to IL-10 ratios
over both time periods suggests that IL-10 improvements may occur later than the time period of
study.
Passive exercise should be studied as an approach to facilitating mobilization in
mechanically ventilated critically ill adults until they are ready to participate in more active
exercise. It could be that more aggressive exercise, such as passive cycling at faster rates, will be
tolerated in this population. Cytokines may be used to explain benefits of mobilization in this
population.
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Introduction and Background
Muscle weakness commonly occurs after a critical illness, contributing to fatigue, poor
functional status and decreased health-related quality of life long after the critical illness has
resolved.1,2 Immobility and the inflammatory process diminish both muscle mass and strength,
which can prolong need for mechanical ventilation, extend hospital stay, and complicate
recovery, as well as negatively impact quality of life for the individual with critical illness.3,4
Progressive mobilization interventions, from passive and active range of motion (ROM), to
dangling, standing or lift transfer to a chair, and ambulation,5-7 have been recommended as one
approach to minimizing muscle weakness after a critical illness.8 Mobilization is hypothesized to
preserve muscle strength and mass by improving blood flow, stimulating anti-inflammatory
cytokine production and enhancing insulin activity and glucose uptake in muscle.4
Mobilization has been shown to improve outcomes for critically ill adults. Positive
outcomes related to mobilization include significantly shorter lengths of intensive care unit
(ICU) and hospital stays and improved functional outcomes.5,7 In one study where ventilator time
and length of stay were not significantly decreased after employing an exercise protocol,
significantly lower costs for after-hospital care and improved quality of life were noted.9
Several issues complicate the delivery of mobilization interventions, including timing of
the interventions, widely variable practices, and the possibility that mobilization and related
factors such as pain can aggravate the inflammatory process. Optimal timing for initiating
mobilization is not known. Several studies have begun mobilization 5 days or longer after illness
onset,6,10 but with muscle loss beginning within the first twenty-four hours of critical illness, this
time frame misses an important window of opportunity to improve outcomes. Early mobilization
(within the first 24-48 hours of critical illness) has been advocated,11,12 and the feasibility of
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early mobilization, within 24 hours of intubation, has recently been demonstrated.5,13 However,
physiologic instability commonly occurs early in critical illness, and providers may be reluctant
to mobilize a patient who is physiologically unstable. Activity intolerance, manifested as
unstable vital signs, is often a limiting factor in application of mobilization activities,5,8 and
many patients have been unable to participate in progressive therapy sessions because of
physiologic instability.13 Physiologic instability in mechanically ventilated critically ill patients
may persist for days to weeks, delaying active mobility interventions, which may add to
disability.9,14 It may be that passive exercise is the most appropriate activity for critically ill
patients in the early phase of illness,8 and it can be employed until a patient is ready to progress
to more active interventions. However, limited empirical evidence exists to support the safety or
efficacy of passive activity, particularly during periods of physiologic instability. Further, criteria
to document readiness to institute or progress mobilization have not yet been developed.
Tolerance of passive activity may be one signal that institution and progression are appropriate.
Another concern is that mobilization practices vary widely. Practices for active
mobilization include active or resistive range of motion, chair sitting, dangling, standing,
ambulating, and use of a tilt table.5-7 Passive activities also vary. Passive activity can be
delivered manually by therapists or nurses, or via machines such as cycle ergometers or
continuous passive motion machines. Studies have reported manual passive exercise repetitions
of 5, 7, and 10 per joint, but no rationales were provided for these choices.5,15,16 In two separate
surveys of physical therapist practices, 2-30 (mean=13) repetitions per joint and 1-20 (mean 5)
repetitions per joint per day in were reported. 17,18 Several studies used a specified time rather
than repetitions per joint for ROM. Time periods ranged from 20 minutes19 to 26 + 14 minutes.13
Burtin et al. added 20 minutes of passive activity via a passive cycling machine to a mobilization
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protocol.10 With treatment routines varying widely, it is difficult to compare patient outcomes.
Standardized mobilization routines that consider therapeutic parameters of duration, intensity
and frequency, and that may be readily replicated and applied in critically ill patients are critical
to demonstrating improved outcomes from mobilization. Mechanical devices, such as continuous
passive motion machines and passive cycling devices, have been suggested as an approach to
standardize therapy at a duration and intensity that can meet prescriptive guidelines.10,15
Further concern has been expressed that early mobilization contributes to increased
muscle inflammation, which may compound rather than prevent muscle weakness.20
Inflammatory markers did not significantly change with passive activity less than 15 minutes
duration, suggesting that passive activity does not increase inflammation.21 Whether a decrease
in inflammation could be attributed to activity and improved outcomes is not yet known, but
preliminary evidence suggests that 20 minutes of sustained activity daily could improve cytokine
profiles in critically ill patients.19 Further study would add to safety support for this measure as
well as possibly provide a physiologic explanation for benefit of mobilization.
The effect of mobilization on pain in critically ill patients has not been studied, and it is not
known whether mobilization causes or reduces pain.22,23 Pain increases cortisol secretion and
production of pro-inflammatory cytokines, which may be deleterious to muscle.24 Administration
of morphine for pain management decreases inflammatory cytokines, suggesting that managing
pain may be muscle protective.25 Studying the pain response to mobilization may add additional
support to benefits of mobilization or dictate precautions during implementation.
Passive activity, if demonstrated to be safe, may provide early benefit to those critically
ill patients who are not yet able to tolerate progressive activity. This study sought to identify
physiologic, pain and inflammatory responses to a standardized passive exercise intervention
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instituted early in critical illness. Introducing a passive exercise intervention early in critical
illness may be muscle protective, which could facilitate weaning, shorten intensive care unit and
hospitals stays, and improve quality of life for mechanically ventilated critically ill patients.

Methods
Design and Consent
This study used a quasi-experimental within-subjects repeated measures design, with
subjects serving as their own controls. Study participants were enrolled within 48 hours of
intubation, and received a single 20 minute standardized passive exercise intervention within 72
hours of intubation. This time frame was designed to test the intervention on participants early
after intubation, and allowed the intervention to be delivered within a consistent time frame.
Institutional review boards at the clinical agency and university approved the study.
Informed consent was obtained from the proxy for the critically ill patients who met eligibility
criteria. If the patient was responsive at the time of consent, they would have been approached
for consent, but all eligible patients were either sedated or unresponsive.

Setting and Sample
The study was conducted in a tertiary care setting in southeastern United States. Subjects
were recruited from three critical care units: burn-trauma, neuroscience and multisystem. Care in
these settings was directed by either medical or surgical intensivists. The intensivists provided
assent for participant involvement in the study. The electronic medical record was screened daily
in each unit for potential participants.
A convenience sample of 32 critically ill adults was enrolled in the study between
October 2011 and February 2012. Figure 2 demonstrates the screening to enrollment flow chart.
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240 screened

155 met exclusion criteria

4 Physiologically unstable

16 Unable to locate proxy
19 Planned withdrawal
14 Declined

2 deteriorated

32 Consented

30 Proceeded to intervention

Figure 2. Screening to enrollment flow chart.

Inclusion criteria were: age 18 years or older; intubation and mechanical ventilation
initiated within 48 hours of enrollment and anticipated for at least 72 hours; ambulatory prior to
admission, presence of a vascular access device for blood sampling; and vital signs within unitspecified norms (Table 3).

Table 3. Order Set Specified Normal Ranges of Vital Signs.
Variable
Heart rate
Blood pressure
Oxygen saturation
Intracranial pressure

Normal Range
Heart rate > 50/min but < 130/min
Mean arterial blood pressure > 60 mmHg but < 130 mmHg
>88% (to accommodate for potentially low hemoglobin levels,
oxygen saturation >90% was used for this study)
Intracranial pressure < 20 mmHg
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Persons who were hospitalized or non-ambulatory prior to critical illness onset, or with
evidence of active cardiac ischemia, absent or injured limbs, inadequate lower extremity range of
motion, or spinal, pelvic or lower extremity instability were excluded. Two hundred forty
patients were screened and 155 initially met exclusion criteria. Spinal, pelvic or lower extremity
instability was the most common exclusion criteria, followed by evidence of cardiac ischemia.
Patients that were physiologically unstable or had no known proxy were screened daily until
stability was attained, a proxy was located, or the time frame was extended beyond the
intervention window. This resulted in exclusion of an additional 20 patients. Planned withdrawal
of life support provided an additional 19 exclusions, and 14 families declined study involvement.
The intervention was not tested on two participants that were consented: one due to surgery and
the other due to unplanned extubation.
Using G-Power a-priori to calculate sample size, for a medium effect size of .25, a
significance level of .05, power of .80, and the four time point comparisons to baseline, sample
size was calculated at 24. With only three time points for the cytokine values, the calculated
sample size rose to 28. Because the study variables were collected over a short period of time
(about 2 hours), attrition rate was expected to be low once the intervention was begun. However,
because attrition could occur from the time of consent to implementation of the intervention,
allowing for a10% attrition rate, a total sample of 31 was anticipated.

Measures
Demographic and Cardiopulmonary Measures
Demographic data were obtained from the electronic medical record. Existing bedside
monitoring systems (Phillips Intellivue M70) were used to continuously measure heart rate,
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arterial blood pressure, oxygen saturation and ICP. Measures of ICP were obtained when
available but were not required for study enrollment. Standardized placement of monitoring
devices was assured prior to starting the study and measures were taken to assure precision and
accuracy of heart rate, blood pressure, oxygen saturation and ICP measures (Table 4).

Table 4. Measures for Standardized Data Collection of Dependent Variables.
Measure
Heart rate

Blood pressure

Measurement
Technique
5-lead
electrocardiogram

Arterial catheter

Oxygen saturation Pulse oximetry

Intracranial
pressure

Ventricular catheter

Standardized Approach
Lead placement as follow: right arm- under right
clavicle at right bursal junction; right leganterior midline between 7th and 8th right ribs;
left arm- under left clavicle at left bursal
junction; left leg- anterior midline between 7th
and 8th left ribs; V- between fourth and fifth
intercostal spaces, and between left sternal
border and midclavicular line; waveform visible
on monitor
Transducer placed at phlebostatic axis;
waveform visible with three-notch waveform on
monitor corresponding to arterial pulsations;
zeroed against atmospheric pressure.
May be placed on finger, toe, earlobe; waveform
visible with pulsatility on monitor corresponding
to heart rate
Transducer placed level with external auditory
meatus; waveform visible with three-notch
waveform on monitor corresponding to arterial
pulsations; stopcock set to monitor only.

All physiologic values were obtained using the Phillips Intellivue M70 monitoring
systems which are standard at the bedside in the units of study. Sensitivity and specificity data
for this monitoring system is within industry standards and may be found in the operational
manual (both are >.9). Monitor alarms were set at the parameters indicated by critical care order
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sets (Table 3). To assure that measures were synchronous with the intervention, the investigator
used the time displayed on the bedside monitor which was timed to be congruent with data that
downloaded into the electronic medical record.

Pain Measure
The Behavioral Pain Scale, used clinically at the bedside at the time of study, was used as
a pain measure during the study period. It has demonstrated adequate internal reliability with
Cronbach alphas ranging from .64-.72 and intra-class correlations of .95.26, 27 Significant changes
in Behavioral Pain Scale scores have been noted during painful procedures in minimally
responsive adults, supporting validity in this setting.27 Inter-rater reliability for the Behavioral
Pain Scale between the investigator and nurse educator was .95. All Behavioral Pain Scale
measures were obtained by the investigator.

Inflammatory Markers
Interleukin (IL)-6 and IL-10 were used as markers for inflammation during the study
period. The study intervention was completed between 0800 and 1400 to minimize diurnal
effects on cytokine values. Plasma cytokine levels were obtained from either an intra-arterial
catheter or venous access device. There is no known difference between cytokine values
obtained by arterial or venous sampling; however, a direct stick may induce an inflammatory
response and artificially elevate the cytokine levels.28 An established arterial or venous access
device suitable for blood sampling was part of inclusion criteria. Blood samples were obtained,
prepared and analyzed by the investigator according to a predetermined protocol to assure
precision and accuracy (Appendix A). Following generation of a standard curve using known
concentrations of each interleukin, IL-6 and IL-10 values were obtained using a commercially
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prepared human enzyme-linked immunosorbent assay (ELISA). Assays for IL-6 and IL-10
samples were conducted in duplicate and all values were expressed as mean concentrations for
each of the three time periods. The IL-6 to IL-10 ratio was also calculated for each of the three
time points. The ratio between the two values may be clinically important as IL-6 is a proinflammatory cytokine while IL-10 is an anti-inflammatory cytokine that are usually maintained
in approximately 2or 3:1 balance.29

Procedures
Once informed consent was obtained, inclusion and exclusion criteria were re-reviewed
and a decision about the participant’s ability to proceed to the intervention was affirmed. The
study period began with a 30-minute rest period. Prior to start of the rest period, care activities,
such as repositioning, suctioning, examination or hygiene measures, were performed by the
direct care nurse in order to limit the influence of other activity on study outcomes. At the end of
this rest period (T0), baseline measures were obtained: 1) cardiopulmonary measures of heart
rate, mean blood pressure, and oxygen saturation; 2) ICP and the calculated cerebral perfusion
pressure (CPP), if available, 3) a Behavioral Pain Scale score; and 4) a blood sample to assess
cytokine levels. Legs were placed in the continuous passive motion (CPM) machines by the
investigator, and the intervention was started.
Heart rate, systolic, diastolic and mean arterial blood pressures, oxygen saturation, ICP (if
available) and Behavioral Pain Scale score were assessed at 5 minutes (T1) and 10 minutes (T2)
during the intervention, and upon completion of the intervention (at 20 minutes, T3). Legs were
removed from the CPM machines, and 60-minute rest period began. At the end of the rest period
(T4), heart rate, mean blood pressure, oxygen saturation, ICP (if available) and Behavioral Pain
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Scale score were again assessed (T4). A blood sample for assessment of cytokine levels was
obtained upon completion of the PEP (T3) and at the end of the rest period (T4).
Any patient-initiated or provider-initiated activity during the study period was recorded
by the investigator. Family members were allowed to be at the bedside during the intervention if
requested and their presence was also recorded. The investigator was present in the room during
the entire study period and all physiologic measures were directly downloaded into the medical
record and recorded by the investigator.

Intervention
The passive exercise protocol (PEP) consisted of 20 minutes of 20 flexion-extension
(from 70o flexion to 5o flexion) episodes per minute in each leg simultaneously. Leg movements
were alternated so that one leg was flexed while the other was extended, simulating slow
walking.
The CPM machines, manufactured by Furniss Corporation are movement therapy devices
that are approved for use in hospital, rehabilitation and home settings. Two CPM machines were
used for each intervention to standardize the degree of knee and hip flexion. To assure precision
in delivery, the same device was used on each right leg and each left leg for each participant. The
device was placed on the flat surface of the bed below the leg; the leg was positioned in thigh,
calf and foot supports. Supports were padded to prevent skin breakdown, and a stabilizing device
at the knees prevented lateral rotation at the knee or hip. A handheld device was used to set the
number of flexion-extension repetitions per minute (range 1-20) as well as degree of flexion
(range 0o-95o). The CPM machine had a resistance alarm which halted movement as an
additional safety measure. Precision and accuracy have been determined by the manufacturer;
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electrical safety of the equipment was determined by the biomedical engineering department at
the institution. The investigator completed a training program offered by the supplier and
delivered the intervention.

Study End Points
The primary study endpoints were safety endpoints, and included maintenance of heart
rate, mean blood pressure, oxygen saturation, and ICP within the range specified by critical care
order sets (Table 3), during and for 60 minutes after the passive exercise protocol. The secondary
endpoints were maintenance of observed pain level during and 60 minutes after the passive
exercise protocol within one point of baseline, and cytokine levels upon completion and 60
minutes after maintained within 5% of baseline values.

Data Analysis
Repeated measures analysis of variance (rmANOVA) was used to determine whether a
significant change occurred in the heart rate, mean arterial blood pressure, oxygen saturation,
ICP and Behavioral Pain Scale score from baseline (T0) at any of the four subsequent time points
(T1-T4). Repeated measures analysis of variance was also used to determine whether a
significant change occurred in IL-6 and IL-10 levels as well as the ratio between the two from
baseline (T0) at any of the two subsequent time points (T3 and T4). The a-priori level of
significance was set at 0.05 for these tests. As this was primarily a safety study, lack of
significant change in variables was the anticipated outcome. Because changes in the variables
may be statistically significant without being clinically significant, any statistically significant
change in the dependent variables was compared to the clinical parameters previously defined.
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Only statistical significance of change in cytokine levels was considered because clinical
significance is currently unknown.

Results
Sample
Demographic data and baseline characteristics for all participants are summarized in
Table 5.

Table 5. Baseline Sample Characteristics.
Variable
Age in years
Race
Caucasian
African-American
Asian
Ethnicity
Hispanic
Non-Hispanic
Gender
Male
Female
APACHE II
Predicted Death Rate Mean
BMI

Primary Reason for Admission
Neurologic
Respiratory
Abdominal
Cardiac
Hematologic
Sepsis/Infection
Other
Co-morbidities*

Descriptor
Mean (SD) or Frequency (%)
56.5 (16.9); Range 21-90 years
19 (63.3%)
7 (23.3%)
4 (13.3%)
8 (26.7%)
22 (73.3%)
18 (60%)
12 (40%)
23.77 (6.2); Range 13-39
48.8 (19.8); Range 16.5-89.8
28.7 (SD 9.3)
12 overweight
4 Grade I obesity
4 grade III obesity (morbidly obese)
15 (50)
7 (23)
4 (13)
1 (3)
1 (3)
1 (3)
1 (3)
3.93 (1.9); Range 1-8
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Variable
Respiratory
Cardiac
Endocrine
Hematologic
Other
Urinary
Sepsis/Infection
Abdominal
Neurological
Musculoskeletal

Sedation*
Yes
No
Neuromuscular Blockade*
Yes
No
Beta-Blockers within 48 hours of
study participation
Yes
No
Narcotics*
Yes
No
Glasgow Coma Scale Score*
Hemoglobin, mg%*
Glucose, mg/dl*
Ventilator Mode*
SIMV
Assist control
Pressure Support cmH20*
Yes
No
Minute Volume, L/min*
Fraction of inspired oxygen (FiO2)*
Positive end-expiratory pressure,
cmH2O*
Ventilator change during study
period
Yes
No
Activity during the rest period 1

Descriptor
Mean (SD) or Frequency (%)
33
22
21
12
10
8
6
4
1
1
All participants had at least one co-morbid condition; 4
had multiple co-morbidities within the same system
25 (83.3%)
5 (17.7%)
1 (3.3%)
29 (96.7%)

5 (16.7%)
25 (83.3%)
23 (76.6%)
7 (23.3%)
7.8 (2.8); Range 3-13
10.2 (1.8); Range 7.0-14.5
Mean 149.8 (48.7); Range 84-322
16 (53.3%)
14 (46.7%)
11.2 (2.3); Range 10-18
17 (56.7%)
13 (43.3%)
8.5 (2.5); Range 5.5-16.4
35.33% (7.5); Range 30%-60%
5.5 (1.5); Range 5-10
All participants received PEEP

1 (3.3%)
29 (96.7%)
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Variable
Yes
No
Activity during the rest period 2
Yes
No
Hours after intubation
Hours after admission
*at start of intervention

Descriptor
Mean (SD) or Frequency (%)
8 (26.7%)
22 (73.3%)
17 (56.7%)
13 (43.3%)
38.0 (17.6); Range 4.8-67.5
38.9 (18.3); Range 4.0-67

The mean age for participants was 56.5 years (range 21-90 years, SD 17 years); they
were predominantly white (63.3%), non-Hispanic (73.3%), and male (60%); and admitted for
neurologic (50%), respiratory (23%), or gastrointestinal problems (13%). All participants had at
least one co-morbid condition (X=3.93, SD 1.9). The majority of participants were sedated at the
time of the intervention (83.3%) and the mean Glasgow Coma Scale score was 7.8 (SD 2.8).
Drugs used for sedation included fentanyl (70%; mean dose 96.7mcg/hr), midazolam (30%;
mean dose 3.67 mg/hr), and propofol (26.7%; mean dose 35 mcg/kg/min). Seven (23.3%)
participants received a combination of fentanyl and midazolam; 7 (23.3%) received fentanyl and
propofol; 5 (16.7%) received fentanyl alone; 4 (13.3%) received propofol alone; and 2 (7%) were
on benzodiazepines for sedation. Participants were treated with synchronized intermittent
mandatory ventilation (53.3%), pressure support (56.7%) at a mean of 11.2 cmH20 (SD 1.5),
mean minute volume of 8.5 L/min (SD 2.5) , mean FiO2 of 35% (SD 7.5), and all received
positive end expiratory pressure (mean 5.5 cmH2O, SD 1.53). Mean APACHE II score was 23.8
(SD 6.2), with a mean predicted death rate of 48.8 (SD 19.8). The intervention was implemented
a mean 38 hours (SD 17.56) after intubation (mean 38.9 hours after admission, SD 18.34). All
participants were able to complete the intervention, and no adverse events were encountered.
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Physiologic Responses to the PEP
Mean systolic blood pressures ranged from 130.77-135.03 mmHg, diastolic blood
pressures ranged from 65.13-66.10 mmHg, and mean arterial pressure ranged from 86.97-88.20
mmHg across time points. Heart rate means ranged from 91.03-96.20 beats/minute and oxygen
saturation means ranged from 98.07%-98.40% across time points. Sample means were well
within the normal ranges for physiologic variables at all study points (Table 6).

Table 6. Means and Standard Deviations for Physiologic Variables and Behavioral Pain Scale.
Time
0
1
2
3
4
Time

0
1
2
3
4

Systolic BP
Mean
SD
134.07
19.47
131.37
17.36
135.03
28.73
133.70
19.84
130.77
19.41
Heart Rate
Mean
96.20
94.77
93.70
93.00
91.03

SD
18.78
19.43
17.70
18.57
17.52

Diastolic BP
Mean
SD
65.67
12.60
66.10
13.27
65.13
12.27
65.23
12.51
65.87
14.78
Oxygen Saturation
Mean
98.07
98.10
98.40
98.33
98.40

SD
2.49
2.40
1.92
2.06
2.09

Mean BP
Mean
SD
88.20
11.60
87.43
10.99
86.97
10.66
87.70
11.93
87.10
14.40
Behavioral Pain Scale
Score
Mean
SD
3.77
1.04
3.27
.58
3.23
.63
3.27
.83
3.27
.64

Systolic, diastolic and mean blood pressures and oxygen saturation did not change significantly
from baseline at any of the time points (Table 7).
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Table 7. One-way rmANOVA Analyses for Physiologic Variables.
dfa
Fa
pa
Systolic BP
2.04, 59.20
.81
.45
Diastolic BP
1.98, 57.54
.14
.87
Mean BP
2.10, 60.82
.28
.77
Heart rate
2.32, 67.28
2.84
.06
Oxygen saturation
1.85, 53.65
.65
.52
Behavioral Pain Scale score
2.43, 70.42
4.08
.02b
a
Mauchly’s sphericity was significant; the Greenhouse-Geisser epsilon correction is reported;
b
Partial eta-squared was .12, suggesting a moderate effect size
Variable

Although a downward trend in heart rate was noted, the change was not statistically
significant (p=.06). No clinically significant changes warranting discontinuation of the
intervention were noted in any of the physiologic variables.
Only 5 participants had ICP monitoring devices in place at the time of study, which
prevented statistical analysis of the values. Mean ICP values ranged from 5.8-8.8 mmHg,
indicating normal ICP values. The lowest mean ICP was noted at T3. Cerebral perfusion pressure
(CPP), calculated by the monitor interface, ranged from 77-81.2 mmHg, indicating normal CPP
values. The highest mean CPP was noted at T3.

Pain Responses to the PEP
Mean values for the Behavioral Pain Scale scores ranged from 3.23-3.77 and were low
(Table 6), indicating minimal presence of pain behaviors. A significant difference (Table 7) in
the Behavioral Pain Scale scores over time were noted (F(2.43, 70.42)=4.08, p=.02). Pairwise
comparisons showed a significant decrease in pain scores from Time 0 to Time 1 and from Time
0 to Time 2; the decrease was sustained at Times 3 and 4. No clinically significant change
warranting discontinuation of the intervention was noted in the Behavioral Pain Scale score.
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Inflammatory Responses to the PEP
Sample means, standard deviations and ranges are presented in Table 8.

Table 8. Cytokine Variables
Variable
IL-6a

Time 0 Mean
(SD)
872.33
(1432.65)
30.37 (38.23)

Time 3
Mean (SD)
828.53
(1398.69)
29.94 (38.18)

Time 4
Mean (SD)
763.28
(1151.03)
27.78 (35.34)

dfb

Fb

pb

1.60,
4.35a
.03c
43.10
a
IL-10
1.60,
3.03
.07
43.22
IL-6:IL-10
28.82 (47.10) 28.38 (48.81) 28.31 (42.33)
1.61,
3.42
.05d
Ratioa
43.38
a
b
Log transformation; Mauchly’s sphericity was significant, the Greenhouse-Geisser epsilon
correction is reported; cPartial eta squared = .14, suggesting moderate effect size; dPartial eta
squared = .11, suggesting moderate effect size

Baseline IL-6 levels in the sample ranged from 6.77-11048.9 pg/ml; only three
participants had normal IL-6 levels (<29 pg/ml). Baseline IL-10 levels ranged from 6.46-1014.57
pg/ml; only four participants had IL-10 levels within normal range (<10 pg/ml). No correlations
were found between baseline IL-6 values and APACHE II scores or APACHE II predicted death
rates. Additionally, no correlation was found between baseline IL-6 and glucose values. Extreme
outlier values were noted in two of the participants; those participants were excluded from the
final analysis.
A significant difference (Table 8) in the IL-6 values over the three time periods was
noted (F(1.60, 43.1)=4.351, p=.03). Pairwise comparisons showed a significant decrease in IL-6
values from time 1 to time 3 but not from time 3 to time 4. No significant difference was noted in
IL-10 values over the three time periods (Table 8). A significant effect was noted on IL-6 to IL-
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10 ratios over the three time periods (F(1.61, 43.38)=3.42, p=.05). Pairwise comparisons showed
a significant decrease from Time 0 to Time 3 and from Time 3 to Time 4.

Discussion
Early delivery (X=38 hours after intubation) of the PEP was feasible, and limited only by
the protocol-specified time frame (between 0800 and 1400) required to minimize diurnal
variation in cytokine levels. It is possible that the intervention could have been delivered earlier
after mechanical ventilation if the specific time frame for cytokine specimens was not needed.
The physiologic variables used as safety measures were readily available at the bedside and had
direct clinical application to the participant’s care. Baseline hemoglobin values in this sample
were low, supporting the need for a higher minimum (90% vs 88%) oxygen saturation level as a
safety indicator.
The intervention did not adversely change heart rate, blood pressure or oxygen saturation
over the study period, indicating that 20 minutes of passive exercise is safe for critically ill
patients early in the course of their illness. Only 5 (16.7%) participants had received betablockers within 48 hours of the intervention, indicating that a potential increase in heart rate in
response to activity was likely not blunted. The participant tolerance for this level of activity
suggests that multiple episodes of passive activity in a twenty-four hour period may be tolerated
but warrants further research. In addition, more aggressive activity, for example, greater flexion,
more repetitions per minute or longer episodes, may also be tolerated. The CPM machines were
deployed at the maximum rate but greater flexion degrees or longer episodes could have been
utilized, or other options such as passive cycling could have been employed.
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Although only 5 participants had ICP measurements, the trend of the values over time
was interesting. ICP values stayed within normal range during and after the intervention, and the
intervention was able to be completed without any adverse change in ICP. Values trended
downward by the end of the intervention. Similarly, Thelanderson, Cider, and Volkmann studied
ICP response to passive range of motion in 12 participants with parenchymal or intraventricular
catheters and reported a decreased in ICP values from 15 mmHg to 14 mmHg after exercise.16
Their findings combined with data from this indicate the need for further investigation of passive
activity as an approach to lowering ICP in patients with critical neurological illness. This is
especially important as previous studies have found activity to be associated with an increase in
ICP.
The statistical significance of the change in the Behavioral Pain Scale scores during and
after the intervention was an unexpected finding. It may be that mobilization improves patient
comfort level. The clinical significance of a decreased in pain score from 3.77 to 3.23 is
unknown. However, it is important to note that pain score improvement was accompanied by a
decrease in heart rate which supports the clinical significance of the improved pain score in this
sample. Further, because the participants were sedated, minimal change in observed pain
behaviors could be clinically significant.
The high mean and wide range of baseline IL-6 levels is not an unusual finding in
critically ill patients. This study found IL-6 levels to be much higher and IL-10 levels to be much
lower than those reported in another study of chronically critically ill patients.29 However, the
higher IL-6 and lower IL-10 values are consistent with levels in the earlier phase of illness. It is
unusual that baseline IL-6 levels did not correlate with the APACHE II scores and predicted
death rates, as IL-6 is considered to be a reliable indicator of illness severity.30, 31 It may be that
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an injury severity measure would be a more reliable measure than APACHE II given that trauma
patients were included in this study. Timing of the APACHE II measure in relation to study
participation may provide additional explanation. APACHE II scores reflect the first 24 hours of
admission, while the intervention was implemented at a mean of 38 hours after admission. IL-6
levels have also been found to correlate with admission glucose levels, 30, 32 but no correlation
was noted between baseline IL-6 and glucose levels in this study. This may be because glucose
levels recorded for this study were obtained in proximity to the intervention, rather than at
admission. It is likely that glycemic control would have been implemented by the time of the
study start, at a mean of 38 hours after admission.
The change in IL-6 levels over time was an unexpected finding. The significant change in
IL-6 from baseline to the end of the intervention combined with the lack of significant change at
the end of the second rest period supports not only that the PEP did not worsen inflammation, but
it may have been responsible for a decrease in IL-6. Although IL-10 values did not change
significantly over the three time periods, IL-6 to IL-10 ratios significantly improved from
baseline to Time 3 and from Time 3 to Time 4. This suggests that although IL-10 values did not
change significantly, there may have been some contribution from IL-10 increases to the ratio as
IL-6 values did not change significantly from Time 3 to Time 4. It may be that IL-10 changes
occur over a longer period of time than was measured in this study.
While respiratory failure requiring intubation and mechanical ventilation was common to
all participants, this study included participants that were commonly excluded from other
mobilization studies. Participants included those on vasopressors, with neurologic impairment,
intracranial pressure monitoring, open abdomen and intra-abdominal pressure monitoring, and
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neuromuscular blockade. Inclusion of those participants supports passive exercise use in a
broader population of patients than previously considered.
A few limitations were identified. The intervention was delivered between 0800 and 1400
to minimize the influence of diurnal variations on cytokine levels. Participants may be more
fatigued and have less activity tolerance later in the day, and responses may be different if the
intervention is delivered later. Only one episode of passive exercise was studied; it is unknown
how repeated episodes over time will be tolerated. Attempts were made to limit patient and
provider-initiated activity before and after the intervention, but 26.7% of participants had activity
in the rest period before the intervention, and 56.7% had activity in the post-intervention rest
period. While this pattern of activity reflects the care necessary in the critical care setting, it may
have influenced results. Participant mobility level other than not being bedbound prior to
admission was not identified and could also have influenced results.

Implications for Practice and Research
Findings from this study support the safety of early passive exercise in critically ill
patients. Nurses should consider incorporating at least 20 minutes of passive exercise early into
the plan of care for mechanically ventilated critically ill patients so as not to miss opportunities
to improve patient outcomes. Assessment of physiologic values that are commonly monitored in
the critical care setting were used as safety indicators in this study and those same values can be
readily translated into clinical practice. While this study incorporated commonly monitored
values of heart rate, blood pressure and oxygen saturation, it may be that parameters monitored
need to be individualized to the patient. Several study participants had additional physiologic
monitoring to assess cardiac output, intracranial pressure (ICP), and intra-abdominal pressure,
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and while anecdotally no changes were noted, further study is required. This is particularly
important since these types of monitoring are commonly in use, and many mobilization protocols
have excluded patients with these types of monitoring.5, 13
While this study lends further support to safety and feasibility of passive exercise in the
critical care setting, future research should focus on efficacy of early passive exercise within the
context of a mobilization protocol. This study did not include patients with non-invasive positive
pressure ventilation nor with oscillator ventilations, which are commonly used in critical care
settings. Safety, feasibility and efficacy of passive activity should be further investigated in
persons receiving those types of ventilatory support.
Adaptations of passive exercise incorporated into this study should be further explored.
Frequency may be increased from daily up to two, three or four times daily, and duration may be
increased from 20 to 30 minutes per episode. Passive cycling devices have the capacity to
increase duration and frequency beyond the abilities of CPM machines.33 Machines that provide
axial loading and passive walking are available in rehabilitation settings, but have yet to be
studied in the critical care setting.34 Comparative efficacy studies should be conducted to
determine optimum protocols for passive activity.
The finding that passive exercise decreased pain behaviors indicates that mobilization
may serve as a novel approach to pain management in the critically ill patient. Future studies
should incorporate pain responses to mobilization to attempt to replicate these findings. In
addition, future studies should investigate whether mobilization decreases need for narcotics in
the critical care setting.
Although the clinical significance of changes in cytokine values obtained from these
study participants is not known, other studies have demonstrated decreased IL-6 and increased
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IL-10 levels over time in response to regular prescribed exercise.35 Further study of ongoing
passive exercise, rather than the single episode used in this study, may provide clinical
significance for changes in cytokines profiles in response to activity in the critically ill patient.
Despite broader inclusion of critically ill patients in this study, many patients are still
unable to be mobilized. Creative alternatives for those patients should be developed and
investigated. Active arm cycling devices are available but have not yet been adapted for passive
use.33 Electrical muscle stimulation may be used to produce muscle contraction without stretch
and might be a suitable alternative to support muscle integrity in persons with spinal, pelvic or
lower extremity fractures.33 Presence of an arterial or venous access device in the groin was an
exclusion criteria for this study which may have been unnecessary. Perme found no catheterrelated complications in a study of 30 patients who sat, stood or walked with a femoral artery
catheter in place.36
Sedation was administered to 83% of participants in this study. Practice guidelines for the
study units dictate sedation to be adjusted to a Ramsey sedation score of 3 or better, but the mean
GCS score for the study group was 7.8, indicating that patients may have been more deeply
sedated. Passive exercise was not timed with daily sedation withdrawal in this study but could
be considered in future studies. It would also be interesting to see whether early passive exercise
decreases delirium, agitation and the amount of sedation required in mechanically ventilated
critically ill adults. Delirium measures were not incorporated into this study, and previous studies
have used delirium measures only as an explanation for lack of mobilization.5,13 Future studies
should incorporate delirium scales as outcome measures.
The mean baseline blood glucose level for this sample was elevated (149.8 mg/dl; SD
48.7), but glucose level in response to passive exercise was not evaluated. Hyperglycemia is a
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common consequence of critical illness, and it has a direct correlation with IL-6 levels.32 Activity
is known to decrease insulin resistance and increase muscle utilization of glucose.4,32 It is
possible that repeated episodes of passive exercise may not only decrease blood glucose levels
and insulin requirements in critically ill patients, but may decrease IL-6 levels as well. The
relationship between mobilization, IL- 6, blood glucose levels and insulin requirements in
critically ill patients should be explored further.

Conclusion
A passive exercise protocol was well tolerated in a sample of mechanically ventilated
critically ill participants; heart rate, mean blood pressure, and oxygen saturation remained within
unit specified ranges throughout the study period. Behavioral Pain Scale score reductions over
the study period indicated that passive exercise decreased pain during and after the intervention.
Passive exercise reduced IL-6 values but further study will contribute to understanding the
clinical significance of such reductions. Cytokine values may be useful in explaining physiologic
reasons for benefits of mobilization in critically ill adults.
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CHAPTER 4: METHODOLOGY
Abstract
The objective of this study is to identify physiologic variables that could be measured in
response to mobilization interventions in critically ill adults.
Physical activity may mitigate muscle damage from critical illness, but critically ill
patients may have limited activity tolerance. Physiologic measures may be most useful in
identifying safety and efficacy of mobilization in this population.
A comprehensive literature search of electronic databases was conducted from 1990 to
present, including CINAHL, MEDLINE the Cochrane Database of Systematic Reviews, and
PubMed. Search terms used were mobilization, exercise, activity, and critical illness. Seventeen
articles were identified for review. Physiologic measurement approaches were reviewed for
precision and accuracy.
Cardiopulmonary measures comprised the majority of physiologic variables identified,
and multiple measures were used. Physiologic measures were primarily used as indicators of
safety, although several efficacy measures were identified. Only one standardized tool was found
that could be suitable as a safety measure, the Borg Rating of Perceived Exertion. The Medical
Research Council Muscle Strength Grading Scale could be used as a physiologic outcome
measure. Inflammatory biomarkers may be used as a novel measure of physiologic response.
Descriptions of approaches to assure precision and accuracy of physiologic response measures
were extremely limited.
Multiple physiologic variables should be measured when considering response to
mobilization in critically ill patients. Attention should be paid to procedures to assure accuracy
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and precision in measurement. Future studies including physiologic measures should include
inflammatory biomarkers, and other measures of physiologic function, such as pain assessment.

Introduction
Muscle weakness is a common complication of critical illness, and prevention of muscle
weakness is a key factor in recovery from critical illness. Mobilization has been suggested as one
intervention to mitigate muscle weakness (Lee and Higgins 2010). Mobilization activities are a
progressive “class of interventions” (p. 22; Choi, Tasota and Hoffman 2008); interventions begin
with passive range of motion and progress to walking, representing a wide continuum of
activities. Many patients are unable to progress through a continuum of activities in the critical
care, but even minimal activity may be beneficial in preventing muscle weakness. Griffiths et al.
(1995) found that continuous passive exercise in one leg three times a day for seven days
prevented muscle weakness in the treated leg of 5 critically ill patients. Progressive activity in
the critical care setting has been attributed to decreased weaning time in mechanically ventilated
patients, shorter length of stay, and improved function (Bailey et al. 2007; Bourdin et al. 2010;
Burtin et al. 2009; Chiang et al. 2006; Morris et al. 2008; Pohlman et al. 2010; Schweickert et al.
2009). Physical activity is also thought to reduce pain, decrease anxiety, improve delirium,
promote sleep, and improve mood, all of which are beneficial in reducing effects of illness on
muscle (Bailey, Miller and Clemmer 2009; Choi, Tasota and Hoffman 2008).
Although research is beginning to substantiate the benefits of early mobilization,
concerns exist that potential risks mitigate benefits. In healthy individuals, physiologic stress is
an anticipated response to exercise. However, many critically ill individuals have activity
intolerance due to their illness. Primary safety concerns are focused around activity creating
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physiologic instability in a population that is often unstable at baseline. Stiller (2000) proposed
monitoring physiologic responses in critically ill patients during mobilization as the guide for
determining safety, with physiologic responses determining not only when a patient is ready to
begin activity, but also when activity should be halted. Physiologic responses are changes in
measures of physiologic function. Many physiologic functions, such as heart rate, oxygen
saturation, temperature, and blood pressure, are commonly measured by biomedical
instrumentation in use at the bedside in the critical care setting. Physiologic function may also be
measured directly through analysis of metabolic or cellular products in the lab setting, or
indirectly by using tools, such as perception of exertion. Measuring physiologic responses to
activity in critically ill patients serves as the primary measure of safety, and researchers
interested in studying benefits of exercise in critically ill patients cannot study those benefits
without concern for patient safety. This paper critically analyzes specific measures used to
evaluate physiologic responses to mobilization in critically ill patients.

Review of the Literature
A search of the literature was conducted using the search terms, mobilization, exercise,
activity, and critical illness to identify studies that incorporated measures of physiologic
responses to exercise interventions; Table 1 provides operational definitions for these terms.
CINAHL, MEDLINE, the Cochrane Database of Systematic Reviews, and PubMed
databases were examined from 1990 to present. Studies published from 1990 forward were
considered in an effort to reflect current practices; 165 articles were identified that met search
criteria. To be included in the final review, articles met the following criteria: 1) published in the
English language, 2) incorporated mobilization as an intervention in a critically ill (acute or
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chronic) sample, and 3) utilized at least one type of physiologic measure in data collection.
Articles excluded from the review were those that were reviews only (76 excluded), addressed
functional or other outcomes alone, without discussion of physiologic measures (35 excluded),
addressed mobilization after resolution of the critical illness (19 excluded), or written in a
language other than English (19 excluded). Upon selection, articles were reviewed for types of
physiologic measures used as well as approaches taken to assure precision and accuracy.

Results
Seventeen articles were found that met inclusion criteria; a summary of articles reviewed
may be found in Table 9.
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Table 9. Summary of Physiologic Measures Used to Evaluate Response to Mobilization.
Author
Astorino,
Tyerman,
Wong, &
Harness,
2008

Sample and
Setting
9 spinal-cord
injured
participants, ages
26-54 years
(mean 40.6
years);
community
setting

Intervention
30 minutes of
mechanical lower
extremity passive
exercise, with
incremental
increases; repeated
one week later

Measurements*







VO2 and VCO2 by mass
flow sensor
Systolic and diastolic
blood pressures recorded
before, after 15 minutes,
and immediately after
intervention
Peripheral oxygen
saturation
Heart rate
Borg Rating of
Perceived Exertion
(RPE) every 5 minutes
during intervention









Chiang,
Wang, Wu,
Wu, & Wu,
2006

24 males and 8
females; postICU, alert,
mechanically
ventilated; postICU setting

Participants were
randomized to either
physical training
(progressive
upper/lower
extremity range of
motion ROM
exercises) or
standard of care;
both groups






Peripheral oxygen
saturation
Borg Rating of
Perceived Exertion
(RPE) at end of
intervention
Maximum morning ET
pressures (PImax and
PEmax)
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Precision and Accuracy
Approaches
Gas analyzers calibrated
against standard available
precision gases; testretest reliability reported
at .92
Manual recordings of
blood pressure with
recording of first and
fourth sounds; inter-rater
reliability reported at .98
and .93
Oxygen saturation and
heart rate measured by
available standard
biomedical
instrumentation
Patient diary of exercise
and diet habits the day
before each intervention
(to assure situations were
as similar as possible)
Oxygen saturation
measured by available
standard biomedical
instrumentation
Use of standardized
device to measure ET
pressures
Standard rest period
before ET pressure

Additional Measures



Barthel Index (BI)
and Functional
independence
Measure (FIM) at
admission, and at 3
and 6 weeks after
admission (BI and
FIM assessed by a
therapist trained in
its use)

Author

Sample and
Setting

Intervention
subjected to same
weaning protocol

Higuchi,
Kitamura,
Kawashima,
Nakazawa,
Iwaya, &
Yamasaki,
2006

7 males with
complete
quadriplegia,
ages 20-34 years
and six
nondisabled
males, ages 25-35
years; community
setting

Machine guided
passive leg
movement while in
upright position at
preset incremental
rates, from 20-50
movements/minute

Measurements*








Upper/lower extremity
physical strength
measures on admission,
at 3 and 6 weeks after
admission

VO2, VE by mass flow
sensor
Respiratory rate
Heart rate- recorded
only the last 10 secs of
each incremental stage
VO2/Heart Rate ratio
calculated
Blood lactate via earlobe
sample before and after
intervention










Morris, Goad,
Thompson,
Taylor,
Harry,

93 males and 72
females, mean
age 54 years
received mobility

Passive range of
motion delivered
three times a day by
a trained nursing



Limb strength using
Medical Research
Council (MRC)
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Precision and Accuracy
Approaches
measure; repetition of 3-5
ET pressure measures
with averaging of 3
highest values
Strength measures
obtained by dynamometer
following written
directions to standardize
assessments; two raters
pre-tested with 5 subjects
to establish intra-rater
(ICC .91) and inter-rater
(ICC .83) reliability
Gas analyzers calibrated
against standard available
precision gases
Heart rate and respiratory
measured by available
standard biomedical
instrumentation
Blood lactate measured
using calibrated point of
care lactate meter
Refrained from food,
caffeine, and nicotine for
3 hours prior to
intervention
Controlled ambient
temperature and humidity
Limb strength graded by
physical therapists who
have demonstrated inter-

Additional Measures




Days to first out of
bed
Ventilator days

Author
Passmore, et
al., 2008

Muraki &
Tsunawake,
2008

Sample and
Setting
protocol; 88
males 77 females,
mean age 55.4
years received
usual care; ICU
setting
10 males, 10
females; healthy;
ages 18-22 years;
community
setting

Intervention
assistant; five
repetitions per joint

Passive leg cycling
while seated;
progressive increase
from 0-70 rpm over
30 minutes

Measurements*








Pohlman,
Schweickert,
Pohlman,
Nigos,
Pawlik,
Esbrook, et
al., 2010

Richard,
Staley, &

49 sedated,
mechanically
ventilated
participants (27
females, 22
males); mean age
57.7 years (range
36-69 years);
ICU setting

ROM exercises
starting on day 1.5
(range 1-2) after
mechanical
ventilation
commenced; activity
progressed as
tolerated to transfer








10 critically ill
burn patients; 4

Passive or active
ROM delivered by a






examination at discharge
Heart rate
Blood pressure
Oxygen saturation



VO2 and VCO2 by mass
flow sensor
Muscle oxygen
saturation using nearinfrared spectroscopy at
precisely measured
location
Continuous heart rate
(measurement technique
not specified)



Heart rate
Systolic blood pressure
Diastolic blood pressure
Mean blood pressure
Respiratory rate
Peripheral oxygen
saturation
All above recorded at
rest, monitored during
activity and recorded at
completion of
intervention
Heart rate
Systolic blood pressure
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Precision and Accuracy
Approaches
rater reliability on MRC
Heart rate, blood pressure
and oxygen saturation
measured by available
standard biomedical
instrumentation
Gas analyzers calibrated
against standard available
precision gases
Gas measurements taken
each breath and
calculated to average
minute intervals
Muscle oxygen saturation
collected each second and
averaged over 30 minutes
Controlled ambient
temperature and humidity
All values measured by
available standard
biomedical
instrumentation
Standardized rest period
prior to intervention

Additional Measures



ICU length of stay
Hospital length of
stay



Threshold
identification



Ventilator
dysynchrony
Ambulation
distance, balance
Ability to perform
ADLs
Barthel Index (BI)
and Functional
independence
Measure (FIM) on
study entry and at
hospital discharge







All values measured by
available standard

Author
Miller, 1994

Schweickert,
Pohlman,
Pohlman,
Nigos,
Pawlik,
Esbrook, et
al., 2009

Sample and
Setting
males, 6 females;
ages 21-80 years
(mean 48 years);
eight were
mechanically
ventilated; ICU
setting

Intervention

physical therapist on
mean day 13.6
(range 2-47 days)
after injury for mean
duration 22.6 of
minutes (range 1530 minutes) in
supine (in bed)
position
104 sedated,
Participants
mechanically
randomized to
ventilated
exercise and
participants; 29
mobilization on day
females, 20 males of enrollment or
in intervention
standard of care;
group (mean age exercise started with
57.7 years); 23
10 repetitions of
females, 32 males passive range of
(mean age 54.4
motion to each
years) in control
extremity/joint and
group; ICU
progressed to
setting
transfer

Measurements*




Diastolic blood pressure
Mean blood pressure
All values measured
continuously but
recorded before and
after intervention








Systolic blood pressure
Diastolic blood pressure
Mean blood pressure
Heart rate
Respiratory rate
Peripheral oxygen
saturation
Upper/lower extremity
physical strength
measures using Medical
Research Council
(MRC) examination at
discharge
Hand grip strength at
discharge



Heart rate recording
from a bedside monitor
Calculated age-predicted








Stiller,
Phillips, &
Lambert,

31 (18 male, 13
female)
participants, ages

Mobilization
protocol started after
screening for safety

Precision and Accuracy
Approaches
biomedical
instrumentation
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Blood pressure, heart
rate, respiratory rate,
peripheral oxygen
saturation measured by
available standard
biomedical
instrumentation
Strength measures
assessed by two
therapists; assessment
therapists (ATs) different
from interventional
therapists (ITs); ATs
blinded from treatment

ECG tracing satisfactory
Arterial lines calibrated
daily per hospital

Additional Measures





Distance walked
independently at
discharge
Hospital and ICU
length of stay
Functional
independence
Measure (FIM) and
Barthel Index (BI)
at hospital
discharge
(Assessments
conducted by two
therapists;
assessment
therapists (ATs)
different from
interventional
therapists (ITs);
ATs blinded from
treatment)

Author
2004

Sample and
Setting
20-81 years
(mean 57 years);
ICU setting

Intervention
parameters; began
with movement
from lying to sitting
position and
progressed

Measurements*




Winkelman,
2010

14 females, 3
males with acute
COPD
exacerbations and
mechanical
ventilation; ages
35-74 (mean age
60 years); ICU
setting

Observation of
routine therapeutic
mobility as it
occurred; activity
occurred for a
minimum of 20
minutes; activity
consisted of passive
range of motion with
turning and
progression to
ambulation







maximum heart rate
Systolic and diastolic
blood pressures recorded
from oscillometric
sphygmomanometer or
from bedside monitor if
arterial line pressures
displayed
Peripheral oxygen
saturation
PaO2/FIO2 calculated if
data available
Peripheral oxygen
saturation
Partial pressure of
arterial oxygen when
available (calculated P/F
ratio)
Interleukin-6 and
Interleukin-10 at rest
and after activity
Vital signs (type not
specified)

Precision and Accuracy
Approaches
protocol
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Standardized period of
observation to mitigate
diurnal effects
Standardized timing for
collection of resting and
activity blood samples
Vital signs measured by
available standard
biomedical
instrumentation
Intra-rater reliability
established for all data
collection points
Samples obtained and
prepared for analysis by
limited number of people
Samples stored at same
temperature and analyzed
in duplicate by same
method throughout study

Additional Measures




Duration of activity
observed
Activity counts
using an objective
monitor

Author

Sample and
Setting

Intervention

Measurements*


Winslow,
White, &
Tyler, 1990

183 critically ill
adults from 3
hospital settings
(part of a larger
study, age range
and gender NA)

Turning to lateral
position; side
determined
randomly in a
standardized
position





SVO2
Heart rate
Recorded every minute
for 4 minutes



Zannotti,
Felicetti,
Maini, &
Fracchia,
2003

24 ventilatordependent, bedbound patients
with severe endstage COPD;
mean age 65.2
years; post-ICU
setting

Two groups both
received range of
motion twice a day
for 30 minutes; one
group randomized to
range of motion plus
standardized
electrical stimulation
of quadriceps and
vastus muscles for
30 minutes twice a
day (5 min at 8Hz
pulses with 25 min
of 35 Hz pulses)



Peripheral oxygen
saturation
Heart rate
Respiratory rate
Muscle strength using
Medical Research
Council (MRC)
examination at study
onset and weekly for
study duration











Precision and Accuracy
Approaches
Sensitivity of analysis
technique 0.5 pg/ml
Standardized rest period
prior to turning
Peripheral oxygen
saturation and heart rate
measured by available
standard biomedical
instrumentation
Inter-rater reliability of
muscle strength
Peripheral oxygen
saturation , heart rate and
respiratory rate measured
by available standard
biomedical
instrumentation

Additional Measures




Number of days
before chair
transfer
Ability to be
weaned

*measurements are continuous unless otherwise specified
Legend: COPD=chronic obstructive pulmonary disease; ECG=electrocardiogram; ET=endotracheal; FiO2=fraction of inspired oxygen; ICU=intensive care unit;
paO2=partial arterial oxygen pressure; ROM=range of motion; SvO2=venous oxygen saturation
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Physiologic responses were typically measured before, during and after mobilization, and
physiologic variables were used as indicators of safety or efficacy, or both. Physiologic measures
characteristically evaluated cardiopulmonary function but other measures were used as well
(Table 10). Multiple rather than single measures of physiologic responses were used, and
efficacy-focused studies incorporated both physiologic variables as well as measures of
functional outcome.

Table 10. Description of Physiologic Measures.
Type of Measure
Heart rate

Blood pressure

Respiratory rate
Oxygen saturation

Description
Electrodes placed on the chest wall to continuously measure changes
in electrical voltage emanating from the heart during depolarization
and repolarization. Voltage changes are amplified and displayed on an
oscilloscope, and converted into a numerical representation of the
systematic depolarization and repolarization. Heart rate is calculated
per minute as the distance between each atrial
repolarization/ventricular depolarization event (the R-R interval).
Directly measured using an indwelling arterial catheter connected to a
transducer with a fluid interface; the arterial pressure waveform is
displayed on an oscilloscope, and converted into a numerical
representation. Indirectly measured by sensing arterial oscillations via
an automated cuff; a representation of the phenomenon is converted
into a numerical representation and displayed on the monitor. Systolic
blood pressure (SBP) is the pressure measured in the arterial system
during left ventricular systole, while diastolic blood pressure (DBP) is
the pressure measured in the arterial system during left ventricular
diastole. Mean pressure represents the average arterial pressure during
one cardiac cycle of systole and diastole. Direct and indirect
approaches measure systolic and diastolic pressure and often provide a
calculation of mean pressure.
Measured by direct observation, sensor detection of movement, or
flow-direction sensing via a breathing circuit attached to a ventilator.
Measured by exposing hemoglobin to red and infrared light using a
light emitting diode (LED). Oxygenated hemoglobin absorbs more
infrared light, while non-oxygenated hemoglobin absorbs red light. As
light passes through the hemoglobin, a light receiving diode (LRD)
sensor calculates the percentage of each type of light and displays the
value as a percentage; complete saturation is 100%. Pulse oximetry is
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Type of Measure

Metabolic activity:
oxygen consumption
and carbon dioxide
production

Neurodynamic
measures

Description
the most commonly used measure of oxygen saturation and is a
standard monitoring technique in the critical care setting. The LED
and LRD are placed over an accessible peripheral arterial bed, and an
external monitor converts two wavelengths of light signal into a
numeric display with a waveform corresponding to arterial pulsation.
Many sites on the body may be used for sensor placement, including
the fingertip, toe, ear lobe, tip of the nose, heel, hand, or forehead.
Central venous oxygen saturation may be measured by an indwelling
catheter that emits light and senses received light as blood flows past.
The device may be placed in the jugular vein or pulmonary artery, and
is used to calculate oxygen extraction by comparing values to arterial
samples (thus, it is a direct measure of oxygen consumption). It is
invasive, used only in the critical care and surgical settings (and not
widely used even in those settings), and requires skilled personnel for
insertion and use. Intra-arterial devices that continuously detect
oxygen saturation are also available.
Metabolic activity is estimated by VO2 (the difference between inhaled
and expired oxygen concentration), as well as VCO2, (the difference
between inhaled and expired CO2 concentration); the values are
inversely related. The two values may be measured by a volumedisplacing or flow sensing spirometer. VO2 may also be used in
additional calculated measures.
Intracranial pressure may be directly measured via a catheter placed in
the intracranial compartment. The catheter may be placed in the
ventricles (most common), brain parenchyma, subarachnoid or
epidural spaces. It is invasive, used only in the critical care settings
and requires skilled personnel for insertion and use. Fiberoptic and
fluid-filled systems are available. Fiberoptic systems require
calibration prior to insertion. Fluid-filled systems require zeroing, and
the transducer must be placed at the level of the external auditory
meatus. Fiberoptic systems allow measurement of brain temperature
and oxygen when intraparenchymal catheters are used. Cerebral blood
flow is measured noninvasively using Doppler technology; flow is
sensed by placing the probe over windows in the skull.

Efficacy studies rarely incorporated physiologic outcome measures. Only two
standardized tools were located that addressed physiologic responses. One, the Borg Rating of
Perceived Exertion (RPE), represents a safety measure in this population. The other, the Medical
Research Council (MRC) Muscle Strength Grading Scale, represents an efficacy measure.
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Overall, descriptions of approaches to assure precision and accuracy of physiologic response
measures were extremely limited. Discussion of specific measures used to evaluate physiologic
responses to activity or exercise in the critical care setting and related measurement concerns
follows.

Specific Physiologic Measures and Measurement Concerns
Heart Rate
Heart rate (HR) was utilized as a determinant of safety in 12 studies (Table 11).

Table 11. Parameters Used in Studies of Physiologic Responses to Mobilization.
Parameter
Heart rate

Blood pressure

Studies Utilized
Astorino, Tyerman, Wong, & Harness, 2008; Bourdin, Barbier, Burle,
Durante, Passante, et al., 2010; Burtin, Clerckx, Robbeets, Ferdinande,
Langer, et al., 2009; Clini, Crisafulli, Antoni, Beneventi, Trianni, Costi,
et al., 2011; Higuchi, Kitamura, Kawashima, Nakazawa, Iwaya, &
Yamasaki, 2006; Morris, Goad, Thompson, Taylor, Harry, Passmore, et
al., 2008; Pohlman, Schweickert, Pohlman, Nigos, Pawlik, Esbrook, et
al., 2010; Richard, Staley, & Miller, 1994; Schweickert, Pohlman,
Pohlman, Nigos, Pawlik, Esbrook, et al., 2009; Stiller, Phillips, &
Lambert, 2004; Thelandersson, Cider, & Volkmann, 2010; Winslow,
White, & Tyler, 1990; Zannotti, Felicetti, Maini, & Fracchia, 2003
Systolic and Diastolic: Astorino, Tyerman, Wong, & Harness, 2008;
Burtin, Clerckx, Robbeets, Ferdinande, Langer, et al., 2009; Stiller,
Phillips, & Lambert, 2004
Systolic, Diastolic and Mean: Pohlman, Schweickert, Pohlman, Nigos,
Pawlik, Esbrook, et al., 2010; Richard, Staley, & Miller, 1994;
Schweickert, Pohlman, Pohlman, Nigos, Pawlik, Esbrook, et al., 2009
Mean only: Bourdin, Barbier, Burle, Durante, Passante, et al., 2010

Respiratory rate

Not specified: Bailey, Thompsen, Spuhler, Blair, Jewkes, Bezdjian, et al.,
2007; Clini, Crisafulli, Antoni, Beneventi, Trianni, Costi, et al., 2011;
Morris, Goad, Thompson, Taylor, Harry, Passmore, et al., 2008;
Thelandersson, Cider, & Volkmann, 2010
Bourdin, Barbier, Burle, Durante, Passante, et al., 2010; Burtin, Clerckx,
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Parameter

Oxygen saturation

Metabolic activity
Neurodynamic
parameters
Cytokines
Others

Studies Utilized
Robbeets, Ferdinande, Langer, et al., 2009; Higuchi, Kitamura,
Kawashima, Nakazawa, Iwaya, & Yamasaki, 2006; Pohlman,
Schweickert, Pohlman, Nigos, Pawlik, Esbrook, et al., 2010;
Schweickert, Pohlman, Pohlman, Nigos, Pawlik, Esbrook, et al., 2009;
Zannotti, Felicetti, Maini, & Fracchia, 2003
Peripheral oxygen saturation: Astorino, Tyerman, Wong, & Harness,
2008; Bailey, Thompsen, Spuhler, Blair, Jewkes, Bezdjian, et al., 2007;
Bourdin, Barbier, Burle, Durante, Passante, et al., 2010; Burtin, Clerckx,
Robbeets, Ferdinande, Langer, et al., 2009; Chiang, Wang, Wu, Wu, &
Wu, 2006; Clini, Crisafulli, Antoni, Beneventi, Trianni, Costi, et al.,
2011; Morris, Goad, Thompson, Taylor, Harry, Passmore, et al., 2008;
Pohlman, Schweickert, Pohlman, Nigos, Pawlik, Esbrook, et al., 2010;
Schweickert, Pohlman, Pohlman, Nigos, Pawlik, Esbrook, et al., 2009;
Stiller, Phillips, & Lambert, 2004; Winkelman, 2010; Zannotti, Felicetti,
Maini, & Fracchia, 2003
Central venous oxygen saturation: Winslow, White, & Tyler, 1990
VO2/VCO2: Astorino, Tyerman, Wong, & Harness, 2008; Higuchi,
Kitamura, Kawashima, Nakazawa, Iwaya, & Yamasaki, 2006
Thelandersson, Cider, & Volkmann, 2010
Winkelman, Higgins, Chen, & Levine, 2007; Winkelman, 2010
Borg RPE: Astorino, Tyerman, Wong, & Harness, 2008; Chiang, Wang,
Wu, Wu, & Wu, 2006
Airway pressures: Chiang, Wang, Wu, Wu, & Wu, 2006; Clini,
Crisafulli, Antoni, Beneventi, Trianni, Costi, et al., 2011
Muscle strength measures: Chiang, Wang, Wu, Wu, & Wu, 2006; Clini,
Crisafulli, Antoni, Beneventi, Trianni, Costi, et al., 2011; Morris, Goad,
Thompson, Taylor, Harry, Passmore, et al., 2008; Schweickert, Pohlman,
Pohlman, Nigos, Pawlik, Esbrook, et al., 2009; Zannotti, Felicetti, Maini,
& Fracchia, 2003
CAM-ICU: Pohlman, Schweickert, Pohlman, Nigos, Pawlik, Esbrook, et
al., 2010; Schweickert, Pohlman, Pohlman, Nigos, Pawlik, Esbrook, et
al., 2009

Heart rate was measured by a five-lead electrocardiogram (ECG). This measure was
commonly available at the bedside, or included as part of a measurement cart. Although increase
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in heart rate (achievement of a target heart rate) is a desired outcome with exercise, an increase
in heart rate carried a different significance in critical care, and was considered an adverse or
detrimental response. No studies mentioned acceptable heart rate ranges, and only one study
mentioned a specific percent increase in HR (Richard, Staley and Miller 1994). In order to
address clinical significance of heart rate change in this setting, the definitions of an acceptable
or unacceptable heart rate should be addressed. An unstable heart rate may be defined as outside
of accepted parameters (i.e., above or below 60-100/minute), or a percentage increase above
baseline.
Heart rate measures should be timed to capture responses as they occur. Timing was
routinely specified as before (at baseline) and after (upon completion but no longer term) an
intervention. Several studies included measures during the intervention as well, but time points
varied. For example, Higuchi et al. (2006) measured heart rate for 10 seconds before each change
in passive exercise level. Consideration must be given to timing intervals so as to capture
optimum data reflective of the phenomenon of study.
Heart rate alone may be an insufficient measure of cardiac response to mobilization.
Cardiac arrhythmias may be detected on continuous 5-lead ECG monitoring during activity, but
5-lead ECGs may be otherwise limited in the information they supply. If concerns exist about the
passive exercise creating cardiac ischemia, 12-lead or ST-segment monitoring may be more
appropriate measures. Although these monitoring options are available at the bedside, none of
the studies reviewed utilized these advanced forms of monitoring.
Precision and accuracy of HR data depends on standard lead placement. No study
identified that standard lead placement was considered. Further, monitoring devices vary in
accuracy and precision, and these data were rarely reported. Manufacturer reports of accuracy
89

and precision should be considered when using bedside monitoring data for variable
measurement. One last concern is that many extraneous factors, particularly medications, may
influence heart rate. For example, for patients receiving beta-adrenergic antagonists,
tachydysrhythmias may absent as an indicator of activity intolerance.

Blood Pressure
Blood pressure (BP) was measured in eleven of the seventeen studies as a safety measure
(Table 11). The method of measurement (direct vs indirect) was specified in five of the nine
studies. Both measures are available in the critical care setting. One study used an auscultated
method, listening to the first and fourth Korotkoff’s sounds as the BP measure (Astorino et al.
2008). This measure is subject to the individual’s hearing acuity and speed of recognition and is
infrequently used in the critical care setting.
Three different blood pressure values are possible: systolic, diastolic and mean. All three
values are readily available in the critical care setting. Of the 10 studies reporting blood pressure
values, 3 reported systolic and diastolic values only, 3 reported systolic, diastolic and mean
values, one reported mean pressure only, and 3 did not specify blood pressure value measured.
Consideration should be given to which of the three values is most appropriate for the purpose of
measurement. It may be that diastolic pressure is of greatest importance since it represents the
baseline pressure against which the heart needs to pump. Astorino et al. (2008) indicated that
diastolic pressure was the most significant BP measure of safety during mobilization.
Timing of measurement is a concern. The direct method allows for continuous measure
and display of BP values, while the indirect method can provide values as frequently as every
minute. Timing in studies reviewed was routinely specified as before (baseline), during (at
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specified intervals), and after (upon completion but not longer term) an intervention. For
example, Pohlman et al. (2010) used continuous direct BP measures to cross all three time
frames, while Stiller et al. (2004) measured BP indirectly in between activity tasks. Further
considerations in choice of BP method relate to availability and invasiveness. Several researchers
mentioned use of whichever BP method was available at the bedside (Schweickert et al. 2009;
Winkelman 2010). The invasive nature of the direct approach to BP measurement may not be
warranted when precision and accuracy of the indirect method can be assured. However,
repeated cuff measurement can produce pain-induced physiologic changes which may also affect
accuracy of the BP measure.
Precision and accuracy of BP data depend on standard arm and cuff placements and
appropriate sizing for the indirect method or proper transducer placement (at the phlebostatic
axis) for direct measurement. Further, the direct method requires zeroing against atmospheric
pressure. No study in this review identified that standard placements or zeroing were considered.
Monitoring devices vary in accuracy and precision, and similar to heart rate, researchers referred
readers to manufacturer sources for precision and accuracy data. Patient condition or medication
may alter vascular tone and resistance to flow, and should be considered when interpreting the
clinical significance of BP values. Schweickert et al. (2009) identified vasoactive medications
used but did not relate these to BP measures.

Respiratory Rate
Respiratory rate (breaths per minute) was measured in six of the 17 studies (Table 11);
methods for measuring respiratory rate were not specified in those studies. The myriad
influences on respiratory rate render this parameter the least precise measure of response to
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activity, and likely account for the less frequent use of this measure in studies. Bourdin et al.
(2010) used respiratory rate as a safety measure, finding that rate increased with walking and arm
exercise but not with other activities; increase in respiratory rate did not result in stopping the
exercise activity nor did it contribute to adverse events.
A respiratory lead attached to the chest wall senses movement with inspiration and
expiration. Lead placement, depth of respirations, and body habitus determine accuracy of this
approach. The flow-sensing technology in a ventilator has been calibrated by the manufacturer
against a standard and provides the greatest precision and accuracy for this measure. However,
even with flow-sensing technology, critically ill patients that are paralyzed or sedated and on a
controlled mode of ventilation are unlikely to demonstrate change in respiratory rate.

Oxygen Saturation
Twelve of the 17 studies reviewed included peripheral oxygen saturation via pulse
oximetry as a physiologic measure (Table 11). Pulse oximetry is the most commonly used
measure of oxygen saturation and is a standard monitoring technique in the critical care setting.
Central venous oxygen saturation was reported in only one of the studies (Winslow, White &
Tyler, 1990); this approach is invasive and infrequently used in the critical care setting. Muscle
oxygen saturation has been used as a physiologic measure in exercise studies Muraki and
Tsunawake 2008), but this measure provides only a focal measure of oxygen saturation, is
invasive, and not readily available in critical care settings.
Precise and accurate peripheral oxygen saturation values require standard placement of
the LED/LRD sensor, but given the placement options, can vary widely. An adequate waveform
suggests an adequate sample for testing; oxygen saturation values are inaccurate when arterial
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pulsations are not detected. Interpretation of values also requires knowledge of hemoglobin
level; low hemoglobin levels may artificially inflate saturation. Additionally, any factor that
affects peripheral blood flow in the region of measurement can provide inaccurate values.
Examples include systemic vasoconstriction due to disease, drugs, or body temperature. None of
the studies addressed sensor placement, hemoglobin values, confounding factors or waveform
adequacy. The threshold for desaturation was described in 4 reports (Bailey et al. 2007; Burtin et
al. 2009; Pohlman et al. 2010; Schweickert at al. 2009), and varied from <80% to <90%, with no
mention of consideration of hemoglobin values. Monitoring devices also vary in accuracy and
precision, and researchers consistently referred readers to manufacturer sources for precision and
accuracy data.

Oxygen Consumption and Carbon Dioxide Production
VO2 (the difference between inhaled and expired oxygen concentration), as well as
VCO2, (the difference between inhaled and expired CO2 concentration) were reported measures
in 2 studies (Astorino et al. 2008; Higuchi et al. 2006). Flow-sensing spirometry was used, and
precision was determined by calibration against precision gases. Specific protocols were
implemented to standardize timing of measurement in relation to intervention, and ambient
temperature and humidity were controlled to improve precision (Astorino et al. 2008; Higuchi et
al. 2006). Ventilators used in this setting often have built in flow sensors that have the capability
to provide continuous feedback of ventilatory measures, and if available, could be used.
However, these measures do not reflect daily practice. To assure precision and accuracy,
ventilators are calibrated by the manufacturer against standard precision gases and periodically
during use in the same manner per manufacturer guidelines. In the critical care setting, pressure
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support and volume controls may alter these values and must be considered when interpreting the
values. Ventilator parameters should not be changed during measurement periods where
possible. Bailey et al. (2007) described increasing FiO2 by 0.2 prior to mobilization as a preemptive approach.

Neurodynamic Parameters
Intracranial pressure (ICP) and cerebral blood flow (CBF) are two neurodynamic
parameters routinely used in patients with critical neurologic illness. Only one study was found
that measured neurodynamic parameters. Thelandersson, Cider and Volkmann (2010) directly
measured ICP via a ventricular catheter, and indirectly measured CBF using transcranial
Doppler. ICP monitoring is invasive, and CBF measured by transcranial Doppler is noninvasive.
Invasive measures of CBF are available but infrequently used in clinical settings.
Accuracy and precision of ICP are dependent on transducer placement and stopcock direction if
a drainage system is used. The monitoring system was not specified, but may require calibration
prior to insertion, or zeroing if a fluid interface is used. Accuracy and precision of transcranial
Doppler measurement of CBF is dependent on practitioner training as well as device standards
determined by the manufacturer.

Inflammatory Markers
Critical illness has been associated with inflammation (Winkelman, Higgins, Chen, &
Levine 2007), and exercise has been reported to both increase and decrease inflammation (SariSarraf, Reilly, & Doran, 2006). This suggests that inflammatory markers may be useful in
identifying both beneficial and adverse responses to activity in critically ill patients. Cytokine
levels have been used as an in vitro indicator of inflammation, marking illness severity as well as
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a response to therapeutic interventions. Cytokine sample must be obtained in a precise manner if
it is to be an accurate marker. Specific approaches that enhance precision and accuracy of
cytokine values obtained are (Zhou et al. 2010):


Obtaining the sample from the appropriate source. Cytokines may be found in many bodily
fluids and tissues, such as blood, breast milk, urine, and saliva (Sari-Sarraf, Reilly and Doran
2006). Natural cytokine levels may differ in each of these areas, so consideration must be
given to using the correct source. Blood provides the optimum systemic measures of cytokine
activity, but salivary samples may be considered because they are more easily obtained.



Obtaining the sample at the appropriate time. Diurnal influences may cause cytokine levels to
differ by time to day. Obtaining samples at a consistent time of day is important in sample
reliability.



Limiting extraneous influences on cytokine levels. Activity, especially seizures, agitation and
shivering can alter cytokine levels. Care should be taken to control activity to the extent
possible or provide a period of rest before sampling to assure reliability. Feedings and lipids
can also increase cytokine levels. Sampling should be timed during a fast for accuracy; if
fasting samples are not possible, then the influence of feeding on cytokine level should be
taken into consideration.



Obtaining the sample in the appropriate manner. No evidence was found of any difference
between arterial and venous cytokine levels, but a needle stick or venous catheter may invoke
a local inflammatory response. Use of existing arterial or venous access devices may
eliminate this influence. It is also important to obtain the appropriate amount of sample,
usually a minimum of 3 ml.
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Preparing and storing the sample appropriately. Cytokines degrade soon after a sample is
obtained, and should be prepared immediately after a draw. The blood sample is centrifuged,
and serum is removed and frozen at -80oC until analyzed.



Analyzing the samples in the most beneficial manner. Multiplex arrays allow analysis of
cytokine interactions rather than providing simple levels as ELISA measures do.

Winkelman (2010) collected blood samples for IL-6 and IL-10 immediately before and after a 20
minute activity period. Samples were obtained from existing venous or arterial access, aliquoted
and frozen according to a specific protocol, and analyzed in duplicate for accuracy using
established detection limits and sensitivity of 0.5pg/ml. In a related study, Winkelman, Higgins,
Chen, and Levine (2007) used an ELISA analysis with predetermined sensitivity and precision.

Other Measures
Borg Rating of Perceived Exertion
Perceived exertion is often used as a compare measure to physiologic responses in
exercise studies. Two of the 17 studies used the Borg Rating of Perceived Exertion (RPE) scale
in studies of physiologic responses to mobilization (Astorino et al. 2008; Chiang et al. 2006).
The Borg RPE (Table 12) was initially developed in 1970, with the intention of using it as a
proxy measure of intensity in research studies evaluating exertion during exercise (Borg 1970).

96

Table 12. Borg Rating of Perceived Exertion (Chen, Fan, and Moe 2002).
Score
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Verbal Anchor
No exertion at all
Extremely light
Very light
Light
Somewhat hard
Hard (heavy)
Very hard
Extremely hard
Maximal exertion

Therapeutic exercise has three domains: duration, intensity and frequency. Intensity is the
most subjective domain, and the Borg RPE was developed as an attempt to quantify this domain
in relation to physiologic variables. It was normed in healthy adult males exercising to
exhaustion on a cycle ergometer. The unidimensional scale has numeric ratings from 6 to 20 with
verbal anchors along the scale that are purported to indicate sequentially increasing exercise
intensity. The scale range corresponds to one-tenth of the heart rate. Numeric values were added
to render the tool less subject to psychological variables impacting perceived exertion. Initial
work revealed strong correlations between heart rate and the Borg RPE. One concern with the
scale is that the verbal anchors of numerical values imply interval level data when the data is
actually categorical. Yet, Dawes (2010) found good agreement between verbal anchors and
numerical values with intra-class correlations of .96-.98, and box plots showed a sigmoid shaped
curve which corresponded with differences in ratings. Criterion-related validity has been
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reported at .8-.9, but a recent meta-analysis of 164 studies using the RPE showed validity
coefficients in the .5-.6 range (Chen, Fan and Moe 2002). Concurrent validity, test-retest
reliability, and sensitivity have been demonstrated in numerous additional studies. Since the
introduction of the RPE, two important adaptations have occurred. One is the CR-10, which is
uses the same verbal anchors as the RPE but rates exertion on a 0-10 scale. The other uses the 620 scale but substitutes breathing-related exertion anchors. Contemporary use is more common
in fitness rather than research settings, although it has been used in studies of COPD patients
(Scott 2004).
There are several limitations to use of the tool that deserve mention. Since the tool was
normed in a healthy population on cycle ergometry, it should be re-evaluated in other
populations using other exercise approaches. Dawes, et al. (2010) found that brain-injured
persons were unable to clearly distinguish anchor differences, which is not surprising since tool
completion requires cognitive appraisal which may be dampened in individuals with brain injury.
Age extremes present similar challenges, with decreased reliability noted in younger children
and older adults. As with many tools, reliability decreases when scores lie at either end of a tool.
Lower correlations have been found when the RPE is compared to physiologic changes other
than heart rate, such as lactate levels or muscle oximetry. One last concern relates to sensitivity
and reliability. Grant et al. (1999) found that Borg RPE demonstrated lower sensitivity to change
than the visual analogue equivalent, but greater sensitivity when used as a measure of fatigue.
The RPE would be challenging to use in the study of physiologic responses to passive
exercise in critically ill population for several reasons. First, minimal exercise is the goal of
mobilization in this population, and scale reliability is lower at this end of the scale. Second, the
population of critically ill adults tends to be older in age, and reliability has been found to be
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lower in older adults (Groslambert and Mahon 2006). Further, with cardiac and other
hemodynamic monitoring being the norm in this setting, it is not necessary to use a proxy
measure of exertion. Last, the cognitive appraisal required for scale completion may be lacking
in study participants because of factors such as illness severity, and concomitant use of pain
medication and sedation.

Muscle Strength
Comparative muscle strength has been used as a measure in mobilization studies. Five
studies of passive exercise incorporated muscle strength as an outcome measure (Zannotti et al.
2003; Chiang et al. 2006; Morris et al. 2008; Schweickert et al. 2009; Clini et al 2011). Several
different approaches to measurement were used. Use of a dynamometer to measure strength is
considered the gold standard of strength measurement (Paternostro-Sluga et al. 2008) but only
two of the studies used this device as a strength measure, and grip strength of hand muscles was
the sole measure. A dynamometer measures muscle strength against a strain-gauge applied
resistance, and devices such as this are not portable and consequently, not readily available in the
critical care setting. Accuracy of dynamometer measures is dependent on manufacturer
standards, but also depends on a consistent position of the extremity measured (Chiang et al.
2006). Repeated measures should be obtained and averaged; adequate time between measures
should be allowed to minimize the effect of fatigue on the muscle.
Manual muscle testing (MMT) was used most commonly to measure strength as an
outcome in the studies; it involves strength assessments by an experienced observer who
evaluates muscle strength against the examiner’s resistance. The examiner then scores the
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strength assessed on the 0-5 Medical Research Council (MRC) Muscle Strength Grading Scale
(Table 13).

Table 13. Medical Research Council Muscle Strength Grading Scale (Paternostro-Sluga, et al.
2008).
Rating
0
1
2
3
4
5

Observation
No muscle contraction is detected.
A trace contraction is noted in the muscle upon palpation
Active movement when gravity is eliminated
Active movement against gravity but not resistance
Active movement against some resistance
Active movement to overcome resistance

The MRC scale was developed in 1976 as a way to standardize muscle assessments for
studies that used muscle strength as an outcome measure. A modified MRC (Paternostro-Sluga et
al. 2008) has been developed which considers range of motion in addition to strength in the
assessments. Inter-rater and intra-rater reliability have been established in a number of studies
(Paternostro-Sluga et al. 2008). Reliability is greatest at the scale ends (0 and 5) while reliability
between scores of 3 and 4 is weakest. MRC scale ratings are dependent on examiner expertise as
well as patient cooperation. To assure reliability of strength measures obtained, the examiner
must be appropriately trained, have inter-rater and intra-rater reliability established, and take
action to assure patient cooperation. Morris et al (2008) established inter-rater reliability among
therapists using the MRC scale for their study, and used therapists performing muscle strength
assessments were blinded to the protocol arm as measures of precision and accuracy.
One unique muscle strength measure found relates to airway pressures. Chiang et al.
(2006) and Clini et al. (2011) used maximum inspiratory and expiratory pressures as a strength
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outcome measure. To assure reliability of measures obtained, the patients were suctioned before
measurement, seated at 45o head of bed elevation, and instructed to maximally inhale then
exhale. Tracheostomy cuff pressures were checked to eliminate the influence of a possible leak,
and a single standardized manometer was used by a single examiner to measure 3-5 pressures
each, which were averaged (Chiang et al. 2006). While this standardized approach can provide a
reliable measure of respiratory muscle strength, it does require patient cooperation which can be
a limitation in the critical care setting.

Discussion and Recommendations
While purpose of measurement guides the specific approach chosen, the setting of the
population of interest determines to a large degree what is possible to measure and how measures
can best be obtained. Responses to passive exercise in the critical care setting are best measured
by cardiopulmonary physiologic variables for several reasons. These variables are reflective of
the type of metabolic activity that exercise produces and translatable across studies. In addition,
physiologic variables are not only readily available in the critical care setting, but those variables
also represent an important safety parameter which can be crucial in the conduct of research in
this setting. Safety of any intervention must be established before efficacy can be demonstrated.
Additional physiologic measures, such as muscle biopsy and electromyography could be
considered when the primary focus is on outcomes of mobilization. However, other less invasive
outcome measures, such as walking distance and grip strength, are available.
Measurement of multiple physiologic variables should be considered where possible. In
this review, no study used just a single measure of physiologic response to passive exercise.
Multiple measures of the same construct improve reliability as well as validity (Waltz, Strickland
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and Lenz 2010). In the critical are setting, use of multiple measures may decrease the influence
of extraneous factors on the measures obtained. Although one tool (the Borg RPE) is available as
a substitute measure for physiologic variables, its substantial limitations in the setting render the
measure less useful than more direct measures of physiologic response.
Noticeably lacking were measures related to comfort, anxiety, mood, and sleep outcomes
related to mobilization. Pain is routinely assessed in critically care settings using valid and
reliable tools for patients unable to verbally indicate pain, such as the Behavioral Pain Scale
(Payen et al. 2001). Two studies in this review included the Confusion Assessment Method for
the Intensive Care Unit (CAM-ICU) as a delirium measure (Schweickert, Pohlman, Pohlman,
Nigos, Pawlik, Esbrook, et al., 2009; Pohlman, Schweickert, Pohlman, Nigos, Pawlik, Esbrook,
et al., 2010). Pohlman, et al. (2010) used the CAM-ICU to explain lack of activity progression,
while Schweickert, et al. (2009) identified fewer CAM-ICU positive days with exercise. This
tool has established reliability and validity in mechanically ventilated and critically ill patients,
and could be considered as an important measure of cognitive response in mobilization studies.
Additional measures of sleep and mood could be considered as significant physiologic outcome
measures in future mobilization studies.
Measurement of some physiologic variables can be invasive, and an invasive device does
not always guarantee greater precision or accuracy. The need for precision and accuracy must be
balanced against the invasiveness of the measurement device. Access is another concern. Most
studies of physiologic variables in the critical care setting capitalize on available monitoring, and
give secondary consideration to invasiveness, precision and accuracy.
Little mention was made in the studies of procedures taken to assure accuracy and
precision when measuring physiologic variables using available monitoring equipment.
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Researchers must become very familiar with the proper use of biomedical instrumentation at the
bedside in the critical care setting to enhance accuracy and precision. Consulting manufacturer
data about methods using to determine sensitivity, specificity, error rates, and other precision
data is essential if the instrumentation is to provide reliable and valid measures of physiologic
data. Further, devices must be utilized in the same manner for each measure, and according to
manufacturer guidelines. These are perhaps the greatest obstacles to accurate and precise
measurement in the clinical setting.
Timing of physiologic measures was consistently identified as before, during, and after
the exercise intervention in this review, but specific time frames beyond that were variable.
Variable timing of measures renders comparisons between studies difficult. Timing of
measurements can be challenging, as it may be difficult to identify the best time to capture a
specific phenomenon. Many of the physiologic variables utilized were continuously displayed or
multiple measures taken and averaged over time. Clearly, if physiologic variables are to be used
in research studies, extensive consideration should be given to timing of those observations.
No mention was made in the studies reviewed of other physiologic variables that can be
measured in the clinical setting that may be affected by passive exercise. For example,
temperature can increase in response to exercise, but it was not mentioned as a variable in any of
the studies. Interestingly, one of the studies reviewed mentioned control of ambient temperature
as an important procedure for assuring reliability of other physiologic measures (Higuchi et al.
2006). Temperature is another physiologic measure that is readily available at the bedside in
critical care setting, but is subject to the same concerns as other physiologic measures using
existing biomedical instrumentation. Consideration should be given to technique (tympanic, oral,
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or core measures) timing of the measurement, and precision and accuracy of the measurement
device.
Mobilization study criteria often excluded participants with neurological problems, and
only one study (Thelandersson, Cider & Volkmann 2010) was found that measured
neurodynamic responses to passive exercise. Further study of intracranial pressure and cerebral
blood flow responses to passive exercise is necessary before excluding study participants with
neurologic problems. Of note is that Thelandersson, Cider and Volkmann (2010) found no
change in ICP during passive exercise, and ICP significantly decreased after passive exercise,
suggesting that activity may improve neurodynamic values. Muscle blood flow is known to
increase during activity, yet no study to date has directly measured muscle blood flow, although
one study was found that measured an analogue, that of muscle oxygen saturation, but in healthy
adults (Muraki and Tsunawake 2008). Future studies may consider measurement of additional
variables to better understand outcomes.
Physiologic measures were used infrequently as outcome measures in studies reviewed,
unless the study outcome focused on safety. Further, in studies evaluating efficacy of passive
exercise, no connection was made between physiologic variables and outcomes. It would
interesting to evaluate whether patients receiving passive or progressive exercise in the critical
care setting actually have improved physiologic parameters (lower resting heart rate or greater
heart rate and blood pressure variability, indicating better vascular tone) in addition to looking at
just functional outcome measures.
Cytokines are the only physiologic variables found in this review that can be identified as
both an outcome measure and a safety measure, and only two studies identified use of cytokine
levels as a physiologic variable to be evaluated in response to mobilization in critically ill adults.
104

Understanding of the contribution of inflammation to muscle damage is rapidly evolving. Future
studies should include inflammatory biomarker measurements as they may be more accurate
measures of the true physiologic response to exercise in the critically ill than the
cardiopulmonary measures consistently found in this literature review.
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APPENDIX A: BLOOD SAMPLING PROTOCOL
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1. Assess patency of existing arterial or venous access device prior to study start.
2. For venous access, swab port for 15 seconds with alcohol swab. Place a 10 ml syringe on
the port and withdraw 2 ml for discard. Swab port again for 15 seconds with alcohol
swab. Place a new 10ml syringe onto the port and withdraw 3ml blood. Swab port for 15
seconds again with alcohol swab. Flush per protocol (2-5 ml in a 10 ml syringe,
depending on device). Transfer sample into a 5 ml green top tube and place on ice. Label
the specimen with the de-identified participant identification code.
3. For arterial access, remove yellow cap (while turned off to the cap) and place a 3 ml
syringe to stopcock. Turn the stopcock and withdraw 2 ml for discard. Return stopcock to
off position. Place a new 3ml syringe over the stopcock. Turn the stopcock and withdraw
3ml blood. . Return stopcock to off position. Replace the yellow cap and flush per
protocol. Transfer sample into a 5 ml green top tube and place on ice. Label the specimen
with the de-identified participant identification code.
4. Once blood specimen is obtained, allow it to clot for 20 minutes, then centrifuge for 20
minutes at 4oC, at 1000g. Aliquot the serum and freeze in a -80oC freezer. (Specimens
will be stored in a research freezer at Orlando Regional Medical Center.)
5. Serum cytokine levels will be analyzed collectively after completion of enrollment and
intervention. Analysis will be conducted using ELISA in the Research Laboratory at
Orlando Health Corporate Medical Education, Research and Training Center, under the
direction of Dr. Ewa Jaruga-Killeen.
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